bims-fagtap Biomed News
on Phage therapies and applications
Issue of 2026–11–15
fifty-six papers selected by
Luca Bolliger, lxBio



  1. Future Sci OA. 2026 Dec;12(1): 2755467
      The global antimicrobial resistance crisis, driven primarily by the ESKAPE pathogen consortium has catalyzed the translation of engineered bacteriophage therapeutics from experimental platforms to clinical-stage precision medicines. Unlike their wild-type counterparts, which are constrained by narrow host ranges, susceptibility to reticuloendothelial clearance, and limited biofilm penetrability, synthetically engineered phages exploit receptor-binding protein remodeling, phage-derived enzymatic depolymerases, CRISPR-Cas3 chromosomal shredding payloads, sequence-independent SASPject delivery vectors, and in vivo microbiome base editors to overcome the multilayered resistance arsenals of MDR ESKAPE organisms. Recent clinical development has generated human evidence across both genetically engineered phage platforms and advanced fixed phage-cocktails. Engineered programmes include CRISPR-Cas3-based LBP-EC01 and SNIPR001, while AP-SA02 represents an analytically characterized fixed multi-phage cocktail targeting Staphylococcus aureus. This review examines engineering strategies, pharmacokinetics, immune-mediated clearance, delivery challenges, clinical evidence, manufacturing, and regulatory pathways. It also discusses emerging regulatory approaches and distinctions between natural and genetically modified phage products. The literature search was conducted from January-June 2026 using PubMed, Scopus, and Google Scholar, supplemented by searches of ClinicalTrials.gov and the websites of the US-FDA and EMA. Overall, this review evaluates the translational potential of engineered phages, identifies barriers to clinical adoption, and considers future developments in precision antimicrobial therapy against multidrug-resistant pathogens.
    Keywords:  ESKAPE pathogens; antimicrobial resistance; clinical trials; engineered phages; good health and well-being; phage depolymerases; phage-antibiotic synergy; regulatory framework
    DOI:  https://doi.org/10.1080/20565623.2026.2755467
  2. Acta Microbiol Immunol Hung. 2026 Nov 12. pii: 030.2026.03120. [Epub ahead of print]
      Diabetes mellitus is one of the most prevalent non-communicable diseases in Indonesia. Diabetic foot ulcer (DFU) infections are among the most severe complications, often leading to bacteremia and mortality. This study aimed to apply a low-volume broth medium supplemented with antibiotics for screening multidrug-resistant (MDR) bacteria. We used modified low-volume medium for bacterial isolation from diabetic foot ulcers. Bacterial identification and antimicrobial susceptibility testing were performed, followed by whole-genome sequencing for resistome analysis. Out of 15 DFU samples, 5 yielded bacteria resistant to amoxicillin and ceftriaxone. Molecular identification using the partial 16S rRNA gene classified these isolates as Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, and Providencia sp. Notably, 5 out of 7 isolates were categorized as MDR due to their resistance to more than three antimicrobial classes. Furthermore, K. pneumoniae L15 exhibited high-level resistance to ceftriaxone with a minimum inhibitory concentration (MIC) of ≥128 µg mL-1. Resistome analysis of K. pneumoniae L15 revealed the presence of aph, blaCTX-M-15, catA2, fosA, qnrS1, sul2, and tetA. Interestingly, blaCTX-M-15 was flanked by mobile genetic elements (MGEs), specifically Tn3 upstream and IS1380 downstream. The blaCTX-M-15 gene structure identified in this study has also been reported in various other Gram-negative bacteria. Detection and analysis of MDR bacterial pathogens in DFU is important for patients care and to decrease spread of MDR pathogens. The blaCTX-M-15 gene in this K. pneumoniae isolate is putatively capable of disseminating to other bacteria via MGEs. Multilocus sequence typing (MLST) determination showed K. pneumoniae L15 in this study belongs to ST14464.
    Keywords:  Klebsiella pneumoniae; diabetic foot ulcer; mobile genetic elements; multidrug-resistant bacteria; resistome analysis
    DOI:  https://doi.org/10.1556/030.2026.03120
  3. Nutrients. 2026 Oct 25. pii: 3508. [Epub ahead of print]18(21):
      Obesity is a complex chronic disease associated with metabolic and inflammatory alterations in which the gut microbiota has emerged as an important contributing factor. Obesity-associated gut dysbiosis involves not only changes in microbial composition but also alterations in microbial functions and metabolites that may affect intestinal barrier integrity, immune regulation, adipose tissue metabolism, insulin sensitivity, and glucose homeostasis. Current microbiota-modulating strategies, including dietary interventions, prebiotics, probiotics, synbiotics, and fecal microbiota transplantation, can influence the gut microbial ecosystem; however, their effects are often highly variable among individuals and generally lack the specificity required to selectively target disease-associated bacterial populations. These limitations have increased interest in precision microbiota modulation, which aims to selectively modify microbial populations, functions, or products while minimizing unnecessary alterations to the remaining microbial community. In this context, bacteriophages represent a promising biological tool because of their ability to specifically target bacterial hosts, offering the possibility of selectively reducing bacterial populations associated with obesity-related metabolic and inflammatory disturbances. Experimental studies and early human trials have shown that bacteriophage-based interventions can modulate gut microbial communities and influence inflammatory responses, supporting their potential relevance to obesity-associated chronic low-grade inflammation. However, no published clinical trials specifically evaluating targeted bacteriophage therapy for obesity treatment were identified, and its efficacy for obesity management remains unestablished. Further research is needed to identify and validate bacterial targets, optimize phage selection and cocktail design, and evaluate phage stability, bacterial resistance, immunomodulatory effects, safety, and host-microbiota interactions before clinical translation can be considered.
    Keywords:  gut dysbiosis; gut microbiota; inflammation; obesity; phage therapy; precision microbiome modulation
    DOI:  https://doi.org/10.3390/nu18213508
  4. Cureus. 2026 Oct;18(10): e117861
      Background The increasing prevalence of multidrug-resistant (MDR) Escherichia coli has created a need for alternative antibacterial approaches. Bacteriophages are being investigated because of their ability to specifically infect and lyse bacterial hosts. However, the host range of individual phages may be limited. The present study evaluated bacteriophages isolated from environmental water sources against clinical MDR E. coli isolates and assessed the observed lytic coverage of a three-phage cocktail. Methods An in vitro experimental study was conducted using 375 MDR E. coli clinical isolates recovered from clinical specimens. Pond water, sewage water, and Ganga water were screened for bacteriophages using a spot assay, followed by plaque assay and plaque purification. Purified phages were propagated, and their titers were determined by plaque assay. The host-range activity of three purified phages was evaluated against all 375 MDR E. coli isolates. The cumulative coverage of a three-phage combination was then derived from the individual host-range results. Lytic activity among the three individual phages was compared using Cochran's Q test, followed by exact McNemar tests with Bonferroni correction. Results Among the 375 MDR E. coli isolates, the highest resistance was observed against ciprofloxacin (95.2%), while the highest susceptibility was observed to amikacin (72.3%). Preliminary spot screening identified phage-associated lysis in 72 (19.2%) isolates, while plaque formation was observed in 36 (9.6%) isolates. Three purified bacteriophages were recovered from pond water, sewage water, and Ganga water and designated Phage-1, Phage-2, and Phage-3, respectively. Their estimated titers were 1.6 × 10¹², 1.7 × 10¹⁶, and 1.9 × 10¹⁵ PFU/mL, respectively. Phage-1 produced detectable lysis in 146 (38.9%) isolates, Phage-2 in 90 (24.0%), and Phage-3 in 169 (45.1%). Cochran's Q test demonstrated a significant overall difference in lytic activity among the three phages (p < 0.001). The difference between Phage-1 and Phage-3 was not statistically significant (p = 0.259). The cumulative coverage of the three phages combined, derived from the individual host-range results, was 260 (69.3%) isolates, while 115 (30.7%) showed no detectable lysis with any of the three phages. Conclusion The study demonstrated that environmental water sources yielded bacteriophages with detectable lytic activity against clinical MDR E. coli isolates. The individual phages showed variable host-range activity, and their combined (cumulative) coverage, derived from the individual host-range results, was broader than that of any individual phage. This represents cumulative phenotypic coverage and should not be interpreted as the result of a separately tested cocktail or as evidence of phage synergy. Further biological, genomic, safety, and efficacy studies are required to evaluate the potential of these bacteriophages for subsequent phage-development research.
    Keywords:  antimicrobial resistance; bacteriophage; escherichia coli; host range; lytic activity; multidrug resistance; phage therapy
    DOI:  https://doi.org/10.7759/cureus.117861
  5. J Clin Med. 2026 Nov 03. pii: 8578. [Epub ahead of print]15(21):
      Diabetic foot syndrome (DFS) is a severe complication affecting millions of people worldwide, yet its clinical management remains predominantly reactive, focusing on established ulcers rather than early preventive measures. Although the role of the cutaneous microbiome in chronic wounds is recognized, longitudinal ecological shifts in the skin of the foot throughout the progression of diabetes mellitus remain underexplored. This structured narrative review evaluates transitional microbial dynamics from intact skin through to active ulceration and explores emerging microbiome-targeted therapies. Based on a structured literature search of PubMed, Scopus, and Web of Science, complemented by citation searching, and a narrative synthesis of 32 selected publications, current evidence suggests that diabetes-associated changes in the cutaneous microbiome involve heterogeneous alterations in microbial diversity and composition, which vary according to microbial community, anatomical location, and clinical status. DFS progression involves a profound ecological collapse, characterized by depletion of protective commensals (e.g., Staphylococcus epidermidis) and the predominance of virulent Staphylococcus aureus lineages alongside Gram-negative anaerobes. Consequently, precision interventions such as topical probiotics, synbiotics, and bacteriophage therapy have substantial potential to disrupt recalcitrant biofilms and reprogram host immunity toward pro-regenerative phenotypes. Ultimately, recognizing the skin as a primary target organ in diabetes mellitus highlights the need to shift DFS management toward a proactive framework. Validating these microbiome-modulating therapies through standardized clinical trials is crucial to restoring host-microbiota symbiosis and ultimately preventing lower-extremity amputations.
    Keywords:  Staphylococcus aureus; bacteriophages; diabetes mellitus; diabetic foot ulcers; dysbiosis; microbiome-targeted therapies; probiotics; skin microbiome
    DOI:  https://doi.org/10.3390/jcm15218578
  6. EClinicalMedicine. 2026 Nov;101 104284
       Background: Diabetic foot ulcers (DFUs) carry risks of recurrence, amputation, and all-cause mortality, but most prediction models address single outcomes and have limited interpretability. We developed an interpretable multi-outcome machine-learning framework for individualised DFU risk assessment and prospective clinical evaluation.
    Methods: We conducted a development and validation study across three hospitals in China from January 1, 2018, to April 30, 2025. We used electronic medical records and follow-up data from 763 patients at Centres A and B to develop and internally validate an ensemble of single-task extreme gradient boosting (ST-XGBoost) and single-task multilayer perceptron (ST-MLP) models to predict cure, recurrence, amputation, and all-cause mortality. The locked ensemble was externally validated in 100 patients at Centre C. Model performance was assessed using discrimination, calibration, and decision curve analysis, with interpretability evaluated using Shapley additive explanations (SHAP). From January 5 to March 5, 2026, we performed a prospective comparative evaluation. We randomised 202 participants (1:1) to usual care or artificial intelligence (AI)-assisted care, of whom 200 were analysed. We compared AI-assisted physician decision-making via an evolvable web-based online prediction platform versus usual care. The outcome was overall quality score of the final clinical recommendation. The platform supports follow-up data collection for future offline model updating.
    Findings: In the training dataset, cure, recurrence, amputation, and all-cause mortality occurred in 638, 208, 226, and 167 patients, respectively; the corresponding numbers in the external validation dataset were 80, 34, 24, and 25. In independent external validation, the ST-XGBoost + ST-MLP ensemble outperformed six comparators, with a macro-averaged AUC of 0.901, accuracy of 0.875, and F1 score of 0.830. Outcome-specific discrimination was highest for amputation (AUC 0.953) and all-cause mortality (AUC 0.951), followed by cure (AUC 0.880) and recurrence (AUC 0.820). In the prospective evaluation, AI-assisted recommendations received higher scores than corresponding clinician recommendations (7.77 vs 6.47; mean difference 1.30, 95% confidence interval (CI) 1.08-1.52; p < 0.0001), with the largest gain in completeness. The AI-assisted group showed better short-term follow-up engagement and glucose-management adherence.
    Interpretation: We demonstrate that integrating gradient-boosted trees and neural networks enables explainable prediction of complex DFU trajectories and may support prioritised, individualised clinical decision-making. Nevertheless, recurrence estimates should be interpreted cautiously.
    Funding: Xuzhou Municipal Health Commission Science and Technology Project (XWYHT20240128).
    Keywords:  Artificial intelligence; Clinical decision support systems; Diabetic foot ulcers; Machine learning; Prognosis
    DOI:  https://doi.org/10.1016/j.eclinm.2026.104284
  7. Front Cell Infect Microbiol. 2026 ;16 2002174
      Oral biofilms are spatially ordered microbial communities whose pathogenic behavior is shaped by more than taxonomic composition. Their development reflects the combined effects of adhesin-receptor recognition, interspecies coaggregation, matrix formation, metabolite exchange, local physicochemical gradients and host-derived selection. Here, we synthesize molecular and ecological evidence on the bacterial cell surface-matrix interface and consider how these interactions contribute to cariogenic, periodontal and peri-implant biofilms. Particular attention is given to glucosyltransferase-dependent polysaccharides, extracellular DNA, amyloidogenic proteins, sortase-anchored surface factors and outer membrane vesicles, together with metabolic interactions involving lactate, arginine, hydrogen peroxide and heme. We further evaluate functional-genomic and systems-level approaches (including transposon sequencing, CRISPR interference, metagenomics, metatranscriptomics, metaproteomics, metabolomics, spatial imaging, genome-scale metabolic modeling and machine learning) while distinguishing association and prediction from experimentally demonstrated mechanism. Emerging interventions are assessed according to their biological target and evidence level, including adhesion blockade, specifically targeted antimicrobials, matrix synthesis inhibition and degradation, quorum interference, probiotics, catalytic nanoparticles, antimicrobial photodynamic therapy and antibiofilm dental materials. Across these approaches, reduction in biofilm biomass is not equivalent to ecological restoration or clinical benefit. Key translational barriers include model fidelity, donor-to-donor variation, spatial heterogeneity, treatment durability, endpoint selection and the limited external validation of many computational and preclinical findings. Future precision strategies should therefore integrate microbial identity, matrix architecture, spatial metabolism and host context, with experimental perturbation used to establish causal vulnerabilities before therapeutic translation.
    Keywords:  extracellular polymeric matrix; functional genomics; microbial coaggregation; multi-omics; oral biofilm; oral microbiome; precision anti-biofilm therapy; spatial microbiology
    DOI:  https://doi.org/10.3389/fcimb.2026.2002174
  8. Rev Recent Clin Trials. 2026 ;21(5): e15748871349555
      Diabetic foot ulcers (DFU) are one of the most serious complications of diabetes. Up to one-third of patients with diabetes mellitus (DM) may experience DFU during their lifetime. DFU is a major contributor to morbidity in diabetic patients. The treatment process is challenging, and the recurrence rate of UUP remains high. Therefore, establishing prevention strategies is the most important point to emphasize. The treatment process is challenging for both the patient and the healthcare team, and treatment outcomes are often unsatisfactory, especially in severe cases. In addition, the recurrence rate is high even though the ulcer has healed. Diagnosis and treatment of vascular disorders, glycemic control, disease, local wound care, and infection diagnosis and treatment should be addressed along with appropriate general health assessment and management. Recent treatments for diabetic foot ulcers (DFUs) have faced reduced effectiveness due to molecular changes, such as increased expression of matrix metalloproteinases (MMPs), decreased growth factors like VEGF and TGF-β, and dysfunction of macrophages during the inflammation and repair stages. Studies have also shown that elevated oxidative stress and chronic inflammation contribute to delayed wound healing, urging novel deliveries for effective treatment. Therefore, recent research focuses on the development of innovative and effective approaches for DFU healing, such as stem cell and nanomaterial-based therapies. This review has aimed to address critical DFUs approaches, such as DFUs risk factors, prevention approaches, stem cell, and nanoparticle-based treatment.
    Keywords:  Diabetic foot ulcers; advanced dressings; diabetes mellitus; glycemic control; innovative therapies; nano-therapy; stem cell therapy; wound healing
    DOI:  https://doi.org/10.2174/0115748871349555250624045824
  9. J Cyst Fibros. 2026 Nov 10. pii: S1569-1993(26)03782-3. [Epub ahead of print]
      A 27-year-old man with cystic fibrosis, prior liver transplantation for advanced cystic fibrosis related liver disease, tacrolimus immunosuppression, multidrug resistant Pseudomonas aeruginosa infection, recurrent drug induced liver injury, and intolerance to elexacaftor/tezacaftor/ivacaftor underwent matched bacteriophage therapy. Intravenous phages were administered at 109 plaque forming units per dose and nebulised phages at 5 × 109 plaque forming units per dose twice daily. Within two days, marked elevations in alanine transaminase, aspartate transaminase, alkaline phosphatase, and gamma glutamyl transferase developed, prompting treatment cessation. Peak alanine transaminase reached 494 U/L and alkaline phosphatase 527 U/L were observed, while bilirubin and coagulation parameters remained normal. Extensive investigation, including magnetic resonance cholangiopancreatography and medication review, identified no alternative cause. Rechallenge with nebulised phage therapy alone resulted in recurrent liver enzyme elevation after eight days, again resolving following discontinuation. Temporal correlation was demonstrated between liver function test abnormalities and detection of phage DNA in serum and sputum. No bacteriophage neutralisation, bacterial DNAaemia, development of phage resistance, or significant bacterial genomic change was observed. Despite early cessation, lung function improved over the subsequent six months.
    Keywords:  Bacteriophage therapy; Cystic fibrosis; Drug-induced liver injury; Liver transplantation; Pseudomonas aeruginosa
    DOI:  https://doi.org/10.1016/j.jcf.2026.11.002
  10. Breathe (Sheff). 2026 Oct;22(4): 260054
       Background: Nontuberculous mycobacteria (NTM) comprise a diverse group of organisms that can cause pulmonary and extrapulmonary disease. Their management is challenging, because many NTM species exhibit intrinsic antimicrobial resistance; current multidrug treatment regimens have limited efficacy and tolerability; and the number of immunocompromised individuals at risk of NTM disease is increasing. Phage therapy has recently emerged as a potential therapeutic option for refractory NTM pulmonary disease (NTM-PD). This scoping review aimed to map and critically assess the existing evidence on the clinical use of phage therapy for NTM-PD and its reported outcomes.
    Methods: PubMed, SCOPUS, Web of Science and Embase were searched for studies published between August 2015 and August 2025, in any language, addressing phage therapy in NTM-PD. Additional backward and forward citation searches were conducted to identify further relevant studies.
    Results: Five studies met the inclusion criteria: four single-patient case reports and one small case series representing 20 unique patients treated with phage therapy. Of these, 18 had pulmonary NTM disease, mostly involving drug-resistant Mycobacterium abscessus infections treated under compassionate-use protocols or individualised regimens. Reported clinical and microbiological outcomes were inconsistent: some patients showed transient improvement or culture conversion, while others had no measurable benefit. Phage resistance was uncommon but incompletely assessed, and immune-mediated neutralisation emerged as a future concern. No serious adverse events were described.
    Conclusions: Current evidence supports the feasibility but not the efficacy of phage therapy for NTM-PD. Published data are limited to isolated, heterogeneous cases and lack standardised definitions or controlled comparisons. Well-designed, prospective clinical trials are needed to clarify its therapeutic potential and optimise future application.
    DOI:  https://doi.org/10.1183/20734735.0054-2026
  11. J Clin Med. 2026 Nov 03. pii: 8550. [Epub ahead of print]15(21):
      Background/Objectives: Chronic wounds such as diabetic foot ulcers, venous leg ulcers and burns are a major health-care burden. Extracorporeal shock wave therapy (ESWT) is a non-invasive treatment that promotes angiogenesis and tissue regeneration. This review synthesizes the clinical evidence for ESWT in wound management, and asks how contemporary reviews reflect it. Methods: PubMed and Ovid/Embase were searched from inception to 1 September 2026 according to PRISMA, regardless of wound type, study design or ESWT modality. Fifty-one clinical studies and 46 prior reviews were analyzed. Heterogeneity confined the primary synthesis to a qualitative one; an exploratory pooled analysis was performed for the one endpoint reported consistently enough to permit it. Results: None of the 46 previously published reviews covered the original evidence in its full breadth: each cited a median of 19.4% of the clinical studies available at its reference date (range 0-90.9%), and systematic reviews covered no more than narrative ones. Most studies reported improved healing across all four modalities. In seven controlled trials in diabetic foot ulcers reporting complete healing as events and denominators, the exploratory pooled risk ratio favored ESWT (1.51, 95% CI 1.22-1.87; I2 = 0%; 689 patients). Such data existed for three modalities only, resting on one trial for two, so modalities could not be compared. Conclusions: ESWT may be a useful adjunct in wound management, particularly for diabetic foot ulcers, although the evidence is heterogeneous and partly uncontrolled. Because no previous review reflected the evidence base as a whole, conclusions drawn from it should be read with caution. Head-to-head trials with matched physical dose are needed before any modality can be preferred.
    Keywords:  PRISMA systematic review; angiogenesis; diabetic foot ulcer; extracorporeal shock wave therapy; mechanotransduction; regenerative medicine; tissue regeneration; wound healing
    DOI:  https://doi.org/10.3390/jcm15218550
  12. Front Immunol. 2026 ;17 1952662
      Diabetic foot ulcers are chronic wounds characterized by persistent inflammation, defective inflammatory resolution, and impaired tissue repair. Macrophages coordinate host defense, efferocytosis, inflammatory resolution, angiogenesis, and tissue reconstruction, but the diabetic wound environment can impair their adaptation, function, and survival. Ferroptosis, an iron-dependent form of regulated cell death driven by phospholipid peroxidation, has emerged as a potential mechanism linking diabetic wound stress to impaired macrophage function and survival. This review evaluates current evidence for ferroptosis in diabetic foot ulcers and distinguishes evidence from markers and pharmacological rescue obtained at the level of whole wounds from direct evidence in macrophages. We examine how altered iron handling and ferritinophagy, lipid remodeling, impaired glutathione peroxidase 4 activity and complementary antioxidant defenses, inflammatory and immunometabolic stress, and macrophage state may increase ferroptotic susceptibility. We then consider the potential consequences for macrophage functions required for repair, efferocytosis and inflammatory resolution, and support for fibroblasts, endothelial cells, and keratinocytes across wound regions and phases. Current studies support ferroptotic stress as a therapeutically modifiable process in diabetic wounds, but direct in situ evidence of ferroptotic stress or death in defined macrophage populations within human diabetic foot ulcers remains limited. Its biological consequences are also likely to vary according to macrophage state and wound phase. Accordingly, therapeutic strategies should avoid indiscriminate suppression or induction of ferroptosis and instead preserve macrophage functions required for antimicrobial defense, inflammatory resolution, and tissue repair while controlling excessive iron accumulation and phospholipid peroxidation. Spatially resolved biochemical analyses, longitudinal sampling, and functional perturbation in defined macrophage populations will be needed to establish causality and guide treatment according to macrophage state and wound phase.
    Keywords:  diabetic foot ulcer; efferocytosis; ferroptosis; inflammatory resolution; iron metabolism; lipid peroxidation; macrophages; wound healing
    DOI:  https://doi.org/10.3389/fimmu.2026.1952662
  13. Int J Nanomedicine. 2026 ;21 646323
      Periodontitis is a chronic inflammatory disease that leads to the destruction of tooth supporting tissues, including gingival inflammation, periodontal attachment loss, and alveolar bone resorption. Increasing evidence suggests that periodontitis also increases susceptibility to a range of systemic conditions and there is a reciprocal communication between the periodontum and systemic organs. Extracellular vesicles (EVs), as key mediators of intercellular communication, can transport proteins, lipids, and nucleic acids across biological barriers and may play an important role in this crosstalk. In this review, we synthesize current evidence for the involvement of EVs in communication between periodontitis and distant organs. Compared with previous reviews that mainly focus on Porphyromonas gingivalis EVs or one-way effects, we synthesize evidence across multiple EV sources (bacterial, host periodontal, and circulating biofluid EVs) and explicitly review both directions of signaling. At present, the evidence is considerably stronger for periodontal-to-systemic EV effects, particularly in endothelial dysfunction, metabolic reprogramming, osteoclastogenic signaling, and barrier disruption in distant organs, whereas the evidence of systemic EVs on periodontitis remains limited, fragmented, and largely preclinical. This marked imbalance identifies the systemic-to-oral EV pathway as a major knowledge gap in the field. Further studies are needed to define the sources, cargoes, and functional significance of EVs in oral-systemic crosstalk and to clarify their translational potential as biomarkers and therapeutic targets.
    Keywords:  extracellular vesicles; inter-organ communication; periodontitis; systemic disease; therapeutic potential
    DOI:  https://doi.org/10.2147/IJN.S646323
  14. Front Cell Infect Microbiol. 2026 ;16 2002377
      Antimicrobial resistance (AMR) is particularly difficult to manage in immunocompromised hosts, in whom impaired bacterial containment and clearance can coexist with restricted treatment options, altered drug exposure, and anatomically complex infection sites. Susceptibility testing and pharmacokinetic/pharmacodynamic (PK/PD) assessment guide antibiotic treatment, while host defenses help determine whether injured bacteria are cleared. This Review examines the host-antibiotic interface in resistant bacterial infection, with emphasis on how innate immunity contributes to antibacterial activity in immunocompromised populations. We distinguish quantitative and qualitative defects in neutrophils, monocyte hyporesponsiveness, complement impairment, barrier disruption, and combined host deficits, and consider how bacterial burden, infection compartment, and protected intracellular or extracellular populations modify drug-host interactions. Experimental studies show that immune function influences bacterial growth, clearance, and observed antibiotic exposure-response relationships. Antibiotic-induced changes in bacterial morphology, microbial-product release, and immune recognition may promote clearance or inflammatory injury depending on pathogen, burden, timing, and host state. Adjunctive approaches, including colony-stimulating factors, interferon-γ, innate agonists, pathogen-specific antibodies, antibody-antibiotic conjugates, and phage-antibiotic combinations, vary substantially in mechanism and strength of supporting evidence. Clinical assessment of adjunctive strategies requires evidence of improved infection outcomes as well as biological activity. We propose a research-oriented framework integrating antibacterial exposure, bacterial phenotype and burden, infection compartment, and host immune function to guide mechanistic investigation, while retaining effective antibiotic treatment and source control when indicated as the foundations of clinical care.
    Keywords:  adjunctive therapy; antimicrobial resistance; bacterial persistence; host defense; host–antibiotic interface; immunocompromised hosts; innate immunity; pharmacokinetics/pharmacodynamics
    DOI:  https://doi.org/10.3389/fcimb.2026.2002377
  15. J Clin Med. 2026 Nov 09. pii: 8740. [Epub ahead of print]15(21):
      Background/Objectives: Prevention of the first diabetic foot ulcer and subsequent ulcer recurrence is a key priority in diabetes care. Foot orthoses are used to redistribute plantar pressure and protect high-risk areas; however, their effectiveness in preventing ulceration remains uncertain. This systematic review aimed to evaluate the effectiveness of foot orthoses in modifying plantar pressure and preventing first or recurrent diabetic foot ulcers. Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. PubMed, Web of Science, and Embase were searched. Studies were selected according to predefined eligibility criteria related to publication type, language, patient characteristics, and the use of foot orthoses. Methodological quality and risk of bias were assessed using Joanna Briggs Institute critical appraisal tools. Results: The search identified 963 records. After screening and full-text assessment, 12 articles met the inclusion criteria; one additional article was identified and included subsequently, resulting in 13 studies. Overall, foot orthoses reduced plantar pressure, particularly beneath the metatarsal heads. However, the available evidence directly assessing the prevention of first or recurrent diabetic foot ulceration was limited. Conclusions: Foot orthoses may contribute to diabetic foot ulcer prevention by reducing plantar pressure in high-risk areas. Nevertheless, further well-designed longitudinal studies are needed to determine whether these biomechanical improvements translate into a reduction in ulcer incidence and recurrence.
    Keywords:  diabetes-related foot disease; diabetic foot; foot support; injury; insoles
    DOI:  https://doi.org/10.3390/jcm15218740
  16. Healthcare (Basel). 2026 Nov 04. pii: 3770. [Epub ahead of print]14(21):
      Background/Objectives: Metabolic syndrome (MetS) and periodontitis are two of the most common chronic conditions sharing an underlying mechanism represented by systemic inflammation. Smart technologies, including machine learning (ML), wearable and Internet of Things (IoT) devices, telemedicine and intraoral sensors, are increasingly used in both fields. This narrative review examined how these technologies are used to predict, monitor and manage MetS and oral diseases and what evidence supports combining oral and metabolic data. Methods: Following the SANRA framework, PubMed, Scopus and Web of Science were searched for English-language articles published between January 2021 and May 2026. Of the 6922 records identified (3520 after de-duplication), 1852 were screened by title and abstract, and studies were selected by relevance to three research questions. Applications were classified by their current level of evidence. Results: ML models for MetS prediction often reported high discrimination (area under the receiver operating characteristic curve [AUC] up to 0.99), but most were validated only internally, and several used the diagnostic components of MetS as predictors. Wearable, telemedicine and mobile interventions, usually combined with lifestyle programs, were associated with improvements in body weight, blood pressure and glycemic markers; artificial intelligence tools for dental imaging showed accuracy comparable to clinicians in mostly retrospective studies, with limited evidence on patient outcomes. Few studies combined oral and metabolic data: cross-sectional ML studies identified periodontal severity as a predictor of MetS and metabolic conditions as predictors of periodontitis, and salivary glucose correlated with blood glucose mainly in people living with diabetes, which does not establish diagnostic accuracy. No prospective study has tested an integrated dental-medical pathway. Conclusions: Integrating oral and metabolic data through smart technologies is biologically plausible and appears technically feasible, but its added diagnostic value, clinical effectiveness and cost effectiveness have not been established. Externally validated models, prospective cohorts and trials of integrated care pathways are required before routine use.
    Keywords:  artificial intelligence; chronic disease management; machine learning; metabolic syndrome; oral health; periodontitis; saliva; telemedicine; wearable electronic devices
    DOI:  https://doi.org/10.3390/healthcare14213770
  17. Int J Low Extrem Wounds. 2026 Nov 10. 15347346261506987
      BackgroundChronic wounds represent a significant public health challenge because of their prolonged healing time, associated morbidity, impaired quality of life, and substantial healthcare costs. Despite the growing burden of chronic wounds in low- and middle-income countries, longitudinal community-based data evaluating temporal changes in wound epidemiology remain limited in India. This study aimed to compare the prevalence, epidemiological profile, and healthcare-seeking behaviour associated with chronic wounds in two communities of Varanasi, Uttar Pradesh, over a 20-year period.Materials & MethodsA community-based cross-sectional observational study was conducted between June 2022 and December 2023 in the Sunderpur and Kandwa communities of Varanasi district, Uttar Pradesh, India. A total of 10,003 individuals were surveyed using a pretested semi-structured questionnaire and clinical examination. Demographic characteristics, wound aetiology, anatomical distribution, associated comorbidities, and healthcare-seeking behaviour were recorded. Findings were compared with those of a community-based epidemiological study conducted in the same communities in 2003 (n = 6917). Statistical analyses were performed using descriptive and comparative methods, with p < 0.05 considered statistically significant.ResultsNineteen individuals were identified with chronic wounds, yielding an overall prevalence of 1.89 per 1000 population. Urban and rural prevalence rates were 1.57 and 2.64 per 1000 population, respectively. This represented a significant decline compared with the prevalence reported in 2003 (15.03 per 1000 population; p < 0.00001). Compared with 2003, the pattern of wound onset shifted from predominantly traumatic (82.7%) to predominantly spontaneous presentations (84.2%). Lower extremity wounds constituted the majority of cases (89.4%). Diabetic foot ulcers and neglected traumatic wounds were the leading aetiologies, each accounting for 36.8% of chronic wounds. Comorbidities were present in 57.9% of patients, with type 2 diabetes mellitus being the most common (47.4%). A marked change in healthcare-seeking behaviour was observed over the study period, with public-sector healthcare utilization increasing from 37.5% to 68.4%, while reliance on home remedies declined from 50.0% to 5.3%.ConclusionsA substantial reduction in the prevalence of chronic wounds was observed in the studied communities over the past two decades. Chronic wounds continue to predominantly affect the lower extremities and remain closely associated with diabetes mellitus and neglected traumatic injuries. The observed shift toward formal healthcare-seeking behaviour may indicate improved healthcare accessibility and greater awareness regarding wound management within the community. Larger multicentric studies are warranted to confirm these findings and further characterize evolving wound epidemiology in India.
    Keywords:  India; chronic wounds; community-based study; diabetic foot ulcer; epidemiology; prevalence; public health; wound care
    DOI:  https://doi.org/10.1177/15347346261506987
  18. Curr Res Microb Sci. 2026 Dec;11 100678
       Background: Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen frequently associated with multidrug-resistant infections in clinical settings. The rise of antibiotic-resistant strains and their genomic complexity necessitate advanced tools for comprehensive genetic characterization, particularly in the context of resistance to antibiotic and phage therapies.
    Methods: Here, we use ultra-deep high-fidelity (HiFi) sequencing to analyze strain NRD619, a multidrug-resistant P. aeruginosa isolate that had colonized the driveline of a left ventricular assist device of an 82-year-old male who was identified as a phage therapy candidate. Through HiFi long-read sequencing and bioinformatic analysis, we identified low-frequency heterogeneous structural variants (SVs) and investigated their potential phenotypic consequences through functional annotation and literature-based gene-function analysis.
    Results: Small variants in known resistance-associated genes, including an early frameshift in mexZ, were consistent with components of the multidrug-resistant phenotype, whereas several other genotype-phenotype associations remained uncertain. Ultra-deep long-read sequencing identified five low-frequency heterogeneous SV signals. A reciprocal 31.7-kb deletion and duplication of a phage-rich region were supported by 3 and 95 reads, respectively; three multi-kilobase insertion candidates were each supported by a single HiFi molecule. Observed variant allele frequencies ranged from 1.2119% to 0.0122%. The insertions intersected genes involved in type IV pili, transport, and stress response, providing plausible hypotheses for effects on biofilm-related behavior, device colonization, and other phenotypes.
    Conclusions: This study demonstrates how ultra-deep sequencing can uncover cryptic genetic heterogeneity in bacterial pathogens, offering insights into P. aeruginosa population structure in a clinical isolate that are inaccessible to conventional-depth sequencing. Because sequencing followed single-colony recovery and laboratory expansion, the origin and in vivo frequencies of the rarest SVs cannot be established. The detected diversity may reflect structural states accessible in vivo or variation arising during ex vivo propagation; the latter remains relevant because culture-based genomic and phenotypic characterization interrogates the expanded population. Future applications could refine our understanding of multidrug resistance, phage susceptibility, and adaptations influencing host colonization.
    Significance: Chronic bacterial infections are usually represented by a single genome, even though clinicians and microbiologists know genetically diverse subpopulations can coexist within a patient. Using ultra-deep, high-fidelity long-read sequencing of a multidrug-resistant Pseudomonas aeruginosa clinical isolate from a left ventricular assist device-associated infection, we reveal structural heterogeneity distinguished by phage and mobile-element architectures and associated small variants. Coverage-based modeling shows that several of these rare structural states would be poorly sampled at standard sequencing depths, yet they occur in loci linked to virulence, surface interactions, transport, and stress response. Because the isolate underwent single-colony recovery before sequencing, the study cannot determine whether individual rare variants arose in vivo or during ex vivo propagation. Either possibility is informative: the former represents hidden within-host diversity, whereas the latter can alter the population used for culture-based genomic and phenotypic characterization. These findings establish ultra-deep long-read sequencing as a strategy for revealing hidden adaptive potential in chronic and device-associated infection isolates.
    Keywords:  Antibiotic resistance; Efflux pumps; Heterogeneous variants; HiFi sequencing; Multidrug resistance; Pseudomonas aeruginosa; Structural variants
    DOI:  https://doi.org/10.1016/j.crmicr.2026.100678
  19. Ann Med Surg (Lond). 2026 Nov;88(11): 7421-7431
       Background: Hypertension (HTN) is a significant public health concern globally, with Sub-Saharan Africa (SSA) bearing a considerable burden. Dysbiosis of the oral microbiome may play a role in the pathogenesis of HTN, with a scarcity of evidence in SSA. The aim of this review was to explore the existing literature on the influence of oral health and dysbiotic oral microbiomes on the development of HTN in SSA countries.
    Methods: A comprehensive search across electronic databases, including PubMed, Google Scholar, Scopus, ScienceDirect, and Web of Science, was conducted from 2000 up to December 2025. Studies involving SSA populations and addressing the role of the oral microbiome in HTN were included.
    Results: The review identified 12 studies investigating oral microbiota dysbiosis and its association with HTN in six SSA countries (South Africa, Nigeria, Tanzania, Senegal, Ghana, and Cameroon). Of these, 10 studies assessed periodontal diseases using clinical indices as a proxy for dysbiosis, 1 study assessed dental caries, while only a single study performed direct microbial analysis (using 16S rRNA gene sequencing). Eight studies reported quantitative effect estimates: odds ratios for the association between periodontal disease or gingivitis and HTN ranged from 1.5 to 4.30 (all P < 0.05), while one study reported an association between dental caries and HTN (odds ratio, 0.72-0.73). The reported prevalence of HTN ranged between 19.7 and 91.8%.
    Conclusion: This scoping review finds that most available evidence from SSA supports an association between periodontal disease and HTN. However, direct evidence regarding the oral microbiome itself remains very limited, with only one study performing species-level microbial analysis.
    Keywords:  Sub-Saharan Africa; dysbiotic oral microbiome; hypertension; oral health; periodontal diseases
    DOI:  https://doi.org/10.1097/MS9.0000000000005750
  20. JMIR Mhealth Uhealth. 2026 Nov 10. 14 e101195
       Background: Mobile health (mHealth) interventions show promise for supporting diabetic foot self-care; however, sustained engagement remains a challenge, particularly in low- and middle-income countries. While educational strategies are commonly used to address diabetic foot ulcers, they often fail to translate knowledge into long-term self-care. Understanding behavioral mechanisms underlying mHealth use, including the role of caregivers, is critical for improving implementation and effectiveness.
    Objective: This study explored how behavioral interactions between people with diabetes and caregivers shape the use of an mHealth app for diabetic foot self-care.
    Methods: This qualitative explanatory study was embedded within a parent study of an mHealth app for diabetic foot care that was conducted in primary care settings in Peru. It used the COM-B (capability, opportunity, motivation-behavior) model and the Theoretical Domains Framework (TDF) to identify mechanisms relevant for intervention design and scale-up. Semistructured interviews were conducted with people with diabetes and caregivers about their experiences related to accessing the app. Data were analyzed using deductive and inductive thematic analysis informed by the COM-B and TDF.
    Results: In total, 14 people with diabetes (median age 54 y, 8 women and 6 men) and 10 caregivers (median age 28.5 y, all women) were interviewed. The app use depended on varying interactions between COM-B domains, while other behavioral determinants aligned with a single domain. Across domains, interactions between people with diabetes and caregivers also affected the app use. For example, caregivers often compensated for physical capability limitations through foot positioning or environmental adjustments. Environmental context and resources, including internet access, lighting, and device compatibility, affected the app use for all participants. Motivation for all participants was largely driven by beliefs about the app's preventive value, although reassurance from health professionals and altruism also emerged.
    Conclusions: The app use often depended on collaboration between people with diabetes and caregivers as a dyad, rather than on independent users. This highlights the need to design digital interventions around caregiver demographics, competing responsibilities, and the additional responsibilities an app may introduce. Participants' preference for individual follow-up suggests that nonphysician health personnel and other human support may help maintain continuity and reassurance alongside digital monitoring. Although the app was an early prototype intended for algorithmic training, participant experiences provided insight into real-world usability and contextual barriers for future app development.
    Keywords:  AI; COM-B model; TDF; barriers; behavioral change; diabetic foot; facilitators; low- and middle-income countries; mobile health intervention
    DOI:  https://doi.org/10.2196/101195
  21. Front Oral Health. 2026 ;7 1976898
       Background: The oral cavity is continuously exposed to environmental, lifestyle-related, microbial, and systemic influences capable of altering tissue homeostasis and contributing to chronic oral disease. Environmental exposures may interact through inflammatory, microbial, and metabolic pathways affecting both hard and soft oral tissues. This review critically synthesizes current evidence on environment-related oral diseases within the framework of the oral exposome, focusing on environmental determinants, biological mechanisms, tissue alterations, and implications for oral surgery, implantology, regenerative procedures, and precision oral medicine.
    Materials and methods: A comprehensive narrative review was conducted through electronic searches of PubMed, Scopus, and Web of Science for studies published up to April 2026. English-language articles evaluating relationships between environmental exposure and oral tissue alterations were included. Evidence regarding environmental pollutants, smoking, alcohol consumption, dietary factors, occupational exposures, and other external determinants was critically analyzed together with host-related modifiers, including salivary dysfunction, microbial dysbiosis, systemic disease, and chronic inflammatory conditions. The review considered exposure-associated alterations involving dental hard tissues, periodontal and peri-implant structures, oral mucosa, salivary homeostasis, and oral microbial ecology.
    Results: The strength of evidence varied substantially across exposure-outcome relationships. The most mature human evidence concerned conventional tobacco smoking and selected carcinogenic exposures, whereas associations involving air pollution, heavy metals, occupational toxicants, electronic cigarettes, endocrine-disrupting chemicals, and emerging contaminants showed greater heterogeneity and, for several outcomes, relied substantially on observational, experimental, or mechanistic evidence. Across these different levels of evidence, recurrent pathways included oxidative stress, inflammation, microbial dysbiosis, epithelial dysfunction, and altered tissue homeostasis.
    Conclusions: The oral exposome provides a useful framework for understanding the multifactorial nature of oral disease and the interaction among environmental exposure, microbial ecology, host response, and tissue homeostasis.
    Keywords:  bone tissue regeneration; environmental exposure; microbial dysbiosis; oral exposome; oral microbiome; oral mucosal alterations; oral tissue homeostasis; peri-implant disease
    DOI:  https://doi.org/10.3389/froh.2026.1976898
  22. Infection. 2026 Nov 10.
       BACKGROUND: Lung transplant recipients (LTRs) with cystic fibrosis (CF) are frequently colonized with multidrug-resistant pathogens, including extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA), which increase peri-transplant morbidity. Bacteriophage therapy (BT) has shown efficacy against XDR bacteria, but its prophylactic use post-transplant has rarely been reported.
    CASE PRESENTATION: A 46-year-old woman with CF and chronic lung allograft dysfunction (bronchiolitis obliterans syndrome stage III) after bilateral lung transplantation in 2005 underwent retransplantation in 2024. She was colonized with XDR PA and Aspergillus spp. Peri-transplant prophylaxis included ceftolozane/tazobactam, intravenous and inhaled colistin, amoxicillin/clavulanic acid, and intravenous liposomal amphotericin B. BT was personalized based on phage susceptibility testing (PST) and initiated immediately post-transplant via combined intravenous and endobronchial administration for three weeks. Pulmonary cultures remained negative for XDR PA during this period. The patient ultimately developed multiorgan failure unrelated to XDR PA and died 88 days post-transplant.
    CONCLUSION: This is one of the first reported case of prophylactic BT in lung transplantation, achieving pulmonary microbiologic suppression of XDR PA. While the patient's outcome was determined by other complications. Prospective studies are needed to define its efficacy, safety, and optimal administration.
    Keywords:   Pseudomonas aeruginosa ; Bacteriophage therapy; Cystic fibrosis; Lung transplantation
    DOI:  https://doi.org/10.1007/s15010-026-02982-w
  23. Int Wound J. 2026 Nov;pii: e71113. [Epub ahead of print]23(11):
      We examined whether frailty modifies the association between revascularization and major amputation among hospitalizations for diabetic foot ulcer. We identified adult hospitalizations in the National Inpatient Sample from 2016 through 2022 and classified frailty using the 109-code Hospital Frailty Risk Score. Survey-weighted logistic regression assessed major amputation and in-hospital mortality across four frailty strata, adjusting for demographic and clinical characteristics. Among 2 588 159 diabetic foot ulcer hospitalizations, frailty burden exceeded that of diabetes hospitalizations without foot ulcers. The association between revascularization and major amputation weakened with increasing frailty: adjusted odds ratios were 0.30 (95% confidence interval, 0.26-0.35) for low frailty, 0.68 for intermediate frailty and 0.82 for intermediate-high frailty. No statistically significant association was observed for high frailty (adjusted odds ratio, 1.05; 95% confidence interval, 0.86-1.29; interaction p < 0.001). Revascularization was associated with lower in-hospital mortality across frailty strata without significant interaction (p = 0.413). Frailty modified the observed association with major amputation, whereas mortality associations showed limited heterogeneity. Treatment selection and unmeasured clinical differences preclude causal interpretation.
    Keywords:  amputation; diabetic foot; frailty; hospital frailty risk score; revascularization
    DOI:  https://doi.org/10.1111/iwj.71113
  24. J Investig Med. 2026 Nov 09. 10815589261508832
      Chronic wounds represent a major unmet clinical challenge that imposes substantial global healthcare burden, as their pathological mechanisms remain incompletely targeted by existing therapies. Sustained local hypoxia and progressive lactate accumulation are two well-validated, interlinked pathological hallmarks that drive persistent non-healing phenotypes across different etiologies of chronic wounds. Most existing reviews separately describe the regulatory roles of lactate or HIF-1α in wound repair, but few systematically integrate their bidirectional feedback loop and context-dependent, stage-specific effects on multiple reparative cell populations. This narrative review synthesizes current preclinical and clinical evidence to map the complete reciprocal regulatory cascade between lactate and HIF-1α, clarifies their distinct, dose-dependent modulatory effects on fibroblasts, epidermal keratinocytes, and macrophages, and explicitly explains how their self-amplifying signaling loop locks chronic wounds in a sustained inflammatory-metabolic vicious cycle. We further stratify all reported therapeutic interventions along the full lactate-HIF-1α signaling axis, clearly separating preclinically validated strategies from preliminary mechanistic observations and unresolved open questions in the field. This work provides a refined, context-aware reference framework to support the design of stage-matched, precision metabolic therapies for chronic non-healing wounds.
    Keywords:  Chronic Disease; Skin; Wound Healing
    DOI:  https://doi.org/10.1177/10815589261508832
  25. Front Microbiol. 2026 ;17 1971766
      Chronic biofilm-associated infections drive antimicrobial resistance (AMR) via prolonged systemic antibiotic therapy that is often ineffective. Honeys from Apis mellifera and stingless bees (Meliponini) exhibit antimicrobial and anti-biofilm activity via complementary mechanisms: osmotic stress, low pH, hydrogen peroxide, methylglyoxal, bee defensin-1, and phenolic and organic compounds. This is most effective when concentrated at the application site. Yet honey therapeutics are often framed as systemic nutraceuticals despite biologically incoherent pharmacokinetics. We propose translational plausibility, an analytical framework built on four interdependent dimensions: spatial, temporal, dose, and compositional coherence that distinguishes microbiologically defensible interventions from speculative ones, applicable beyond honey to natural-product antimicrobials. Applied to honey, the framework identifies topical, localized application as the only translationally coherent clinical route. Reframed as ecological therapeutic biomaterials, honeys address interconnected AMR priorities: disrupting polymicrobial ESKAPE biofilms, preserving distant microbiotas, reducing systemic antibiotic use in wound care, potentiating antibiotics, and supporting stewardship. Planetary health benefits, pollinator conservation, meliponiculture, and equitable access emerge as corollaries, not primary justification.
    Keywords:  antimicrobial resistance; biofilm; honey; topical application; wound
    DOI:  https://doi.org/10.3389/fmicb.2026.1971766
  26. Diabetes Metab Syndr Obes. 2026 ;19 646224
       Purpose: To quantify the association between exudate amount and time to complete diabetic foot ulcer (DFU) healing.
    Patients and Methods: A retrospective cohort study was conducted among adults in United States outpatient wound care centers with DFUs in the Net Health WoundExpert electronic health record database using available data from 2002-2020. Wounds were followed from first clinic visit until healing or censoring. Exudate amount (none, mild, moderate, heavy) was treated as a time-varying exposure and updated at each clinic visit; the outcome was time to complete healing. Covariates selected for confounding control included demographics, clinical characteristics, and wound-specific factors. To account for time-varying confounding and informative censoring, stabilized inverse probability of treatment and censoring weights were estimated to fit marginal structural models using weighted Royston-Parmar flexible parametric survival models. We estimated hazard ratios (with wound healing as the outcome) and healing probabilities and summarized absolute effects using restricted mean survival times (RMST).
    Results: A total of 8,176 patients with 14,743 DFUs were included (median follow-up: 55 days; mean age: 62 years; 66% male). Higher exudate burden was associated with reduced healing, with adjusted hazard ratios of 0.24 (0.22-0.26), 0.14 (0.13-0.16), and 0.08 (0.06-0.10) for mild, moderate, and heavy exudate, respectively, compared with wounds without exudate (with healing as the endpoint, lower hazard ratios indicate worse outcomes). RMST analyses indicated progressively longer unhealed duration with increasing exudate, with heavy exudate associated with an additional 227 days unhealed by 52 weeks vs no exudate.
    Conclusions: Higher exudate levels were strongly associated with substantially slower DFU healing. Exudate amount may serve as an important prognostic marker and target for intervention in DFU care.
    Keywords:  United States; chronic wounds; diabetic foot; wound care
    DOI:  https://doi.org/10.2147/DMSO.S646224
  27. Int J Microbiol. 2026 ;2026 4040189
      Incomplete bacterial eradication despite appropriate antimicrobial therapy contributes to the progression of some bacterial infections toward chronic or recurrent disease. Beyond genetically encoded antimicrobial resistance, bacterial persistence may be sustained by phenotypically tolerant subpopulations, including persister cells, together with biofilm-associated growth. These states arise within heterogeneous microenvironments shaped by antimicrobial exposure, immune pressure, nutrient and oxygen limitation, and tissue injury. Failure of inflammation to resolve effectively may further promote persistent inflammatory signaling, impaired phagocytic function, localized hypoxia, and extracellular matrix disruption, thereby creating conditions that favor bacterial survival and biofilm stability. This review critically examines the mesenchymal stem cell-derived secretome as a potential host-directed adjunct for persistent and biofilm-associated bacterial infections. Rather than reiterating its antimicrobial, immunomodulatory, and regenerative properties, we integrate direct antibiofilm and antimicrobial evidence with indirect host-mediated mechanisms involving NF-κB modulation, proresolving macrophage responses, efferocytosis, and tissue repair. These actions may converge on host-pathogen niches that sustain bacterial persistence. However, direct evidence that MSC-secretome reduces persister frequency, reverses bacterial dormancy, or eliminates persister populations remains limited. By distinguishing experimentally demonstrated effects from mechanistically inferred actions, this review proposes a host-pathogen ecological framework for evaluating MSC-secretome in bacterial persistence. Current evidence remains predominantly preclinical. Key priorities include improved product standardization and potency assessment, validation in physiologically relevant chronic infection models, and clearer definition of dosing, delivery, and combination strategies with conventional antimicrobials.
    Keywords:  MSC-derived secretome; bacterial persistence; biofilm-associated infection; host-directed therapy; persister cells
    DOI:  https://doi.org/10.1155/ijm/4040189
  28. J Cyst Fibros. 2026 Nov 10. pii: S1569-1993(26)03785-9. [Epub ahead of print]
    Mountain West CF Consortium Investigators
       BACKGROUND: The airway microbiome and host inflammatory response synergistically drive cystic fibrosis (CF) lung disease. We hypothesized that integrating airway microbial community structures with inflammatory biomarker profiles would reveal distinct ecological-inflammatory endotypes associated with clinical outcome measures.
    METHODS: We performed a cross-sectional secondary analysis of 112 clinically stable people with CF. Baseline sputum microbial communities were profiled via 16S rRNA sequencing, clustered using partitioning around medoids and linked with previously quantified inflammatory biomarker data. Co-occurrence network analyses assessed microbial community organisation. Associations with time-to-next pulmonary exacerbation (PEx) and 5-year prognostic survival scores were evaluated utilizing Cox proportional hazards models and multivariable regression.
    RESULTS: Two distinct ecological-inflammatory endotypes were identified. Endotype 1 (n = 65) exhibited higher microbial diversity, enrichment of oral-associated commensals (e.g., Prevotella, Veillonella), a highly interconnected co-occurrence network, and a moderated inflammatory milieu. Endotype 2 (n = 47) was characterized by Pseudomonas dominance, elevated neutrophilic inflammation (e.g., neutrophil elastase, IL-1β), and more advanced lung disease. The two-cluster solution was highly stable under repeated subsampling. Higher microbial diversity was independently associated with a more favourable 5-year prognostic survival score, including after adjustment for endotype membership. Endotype membership itself was not associated with time to subsequent PEx, and associations between ecological measures and PEx were attenuated after additional adjustment for baseline lung function.
    CONCLUSIONS: Distinct ecological-inflammatory endotypes in the CF airway reflect differences in microbial community structure, inflammatory state and underlying disease severity. Longitudinal studies are required to determine the stability of these states and their relationship with subsequent clinical disease.
    Keywords:  Airway microbiome; Endotypes; Inflammation; Microbial ecology; Pulmonary exacerbation
    DOI:  https://doi.org/10.1016/j.jcf.2026.11.005
  29. Mol Biol Rep. 2026 Nov 12. pii: 1954. [Epub ahead of print]53(1):
       BACKGROUND: Diabetic foot ulcers (DFU) are chronic, hard-to-heal wounds that drive diabetic lower-limb complications and can ultimately lead to amputation. Exosomal microRNAs (miRNAs) are promising regulators of ulcer repair by modulating inflammation, promoting angiogenesis, enhancing collagen deposition, and facilitating epithelial regeneration. This study profiled plasma exosomal miRNAs across DFU stages to clarify healing mechanisms and identify potential therapeutic targets.
    METHODS: Whole-blood samples were collected from patients with uncomplicated type 2 diabetes (DM, n = 6) and patients with DFU (n = 13), including an inflammatory-stage group (DFI, n = 7) and a proliferative-stage group (DFP, n = 6).Plasma exosomes were isolated and characterized by transmission electron microscopy, nanoparticle tracking analysis, and Western blotting. Next-generation sequencing was used to compare exosomal miRNA expression between DFU stages and DM, followed by RT-qPCR validation of differentially expressed miRNAs. Bioinformatics analyses were performed to assess involved pathways.
    RESULTS: By comparing the plasma exosomal miRNA profiles of patients with DM and DFU, we found that hsa-miR-744-5p, hsa-miR-432-5p, and hsa-miR-1307-3p were upregulated, whereas hsa-miR-15b -5p, hsa-miR-15a-5p and hsa-miR-144-3p were downregulated in DFU versus DM. RT-qPCR validation confirmed the consistent upregulation of only hsa-miR-744-5p and hsa-miR-1307-3p. KEGG enrichment analysis revealed that the dysregulated miRNAs were primarily associated with inflammation- and angiogenesis-related pathways.
    CONCLUSIONS: The microRNA profiles of plasma exosomes are associated with healing failure in diabetic foot ulcers, with hsa-miR-744-5p and hsa-miR-1307-3p showing sustained upregulation. This suggests that the inflammation-angiogenesis pathway may be involved, indicating that these plasma exosome miRNAs could serve as potential therapeutic targets for DFU.
    TRIAL REGISTRATION: Registration number ChiCTR2500104621; registration date 19 June 2025.
    Keywords:  Circulating exosomes; Diabetic foot ulcers; Exosomal microRNAs; Human plasma; Small RNA sequencing
    DOI:  https://doi.org/10.1007/s11033-026-13073-2
  30. Curr Comput Aided Drug Des. 2026 Nov 11.
       BACKGROUND: Pharmaceutical Research and Development (R&D) is characterized by high costs, lengthy timelines, and frequent clinical failure. Eroom's Law describes the historical decline in new drug approvals per unit of R&D expenditure. Artificial Intelligence-driven Drug Discovery (AIDD) offers new approaches to target identification, molecular design, and property prediction, but improved computational performance alone does not establish clinical benefit.
    OBJECTIVE: This narrative review examines how AIDD can facilitate transitioning from target identification to molecular design and clinical evaluation.
    METHODS: It discusses graph neural networks, structure prediction, and generative models alongside pharmacological and clinical evidence. Four dimensions structure the discussion: target structure and dynamics; subcellular localization and target accessibility; pharmacokinetics and binding kinetics; and clinical factors. They provide a qualitative framework for identifying evidence gaps, not a mathematical model or predictive tool for drug efficacy. A complementary target-molecule-clinical framework illustrates how experimental and clinical evidence can inform earlier stages of drug development.
    RESULTS: Clinical examples, including rentosertib and GTAEXS617, emphasize distinguishing design objectives, preclinical findings, and clinical observations. Rentosertib's phase IIa trial provides an early clinical signal, although its limited sample size and duration preclude conclusions regarding sustained benefit. Training-data bias, data leakage, limited interpretability, synthetic accessibility, and uncertain generalizability beyond the training domain remain important concerns. This review acknowledges selective coverage of the literature and study-design heterogeneity.
    CONCLUSION: Assessing whether AIDD can improve overall drug-development efficiency requires comparative evidence on development time, cost, safety, and clinical success. Experimental validation and longitudinal clinical follow-up remain essential for evaluating these outcomes.
    Keywords:  AlphaFold; Artificial intelligence; Eroom's law; drug discovery; foundation models; systems pharmacology.
    DOI:  https://doi.org/10.2174/0115734099515065261105060228
  31. MedComm (2020). 2026 Nov;7(11): e71120
      Alcohol-associated liver disease (ALD) represents a leading cause of preventable liver-related morbidity and mortality worldwide. Despite its growing global burden, no pharmacological therapies targeting disease progression have achieved clinical approval, with management still centered on alcohol abstinence and supportive care. Classic pathogenic mechanisms, including ethanol metabolism, oxidative stress, innate immune activation, and regulated cell death, are well recognized, yet emerging evidence highlights the gut-liver axis and intestinal dysbiosis as critical, interactive drivers of disease pathophysiology. However, how gut microbial imbalance mechanistically intersects with these canonical pathways to accelerate ALD progression remains insufficiently integrated. This article summarizes the epidemiology, clinical manifestations, and pathogenesis of ALD. Importantly, we focus specifically on changes in the gut microbiota (including bacteria, fungi, and viruses) and microbial metabolites. We further discuss the interactive relationships between dysbiosis and these core mechanisms. Finally, we summarize progress in preclinical and clinical research on targeted strategies such as probiotics, fecal microbiota transplantation, and phage therapy. By synthesizing the research findings, we propose a stage-based, mechanism-oriented framework aimed at advancing the development of safer and more precise therapeutic interventions for ALD.
    Keywords:  alcohol‐associated liver disease; cell death; epidemiology; gut–liver axis; inflammation; microbiota; therapeutic targets
    DOI:  https://doi.org/10.1002/mco2.71120
  32. Pharm Res. 2026 Nov 09.
       PURPOSE: Antibiotic resistance has intensified the need for alternative therapies, such as bacteriophage administration. However, the optimal delivery strategy-specifically simultaneous versus sequential dosing-remains poorly defined for ensuring sustainable efficacy. This single-strain, in vitro proof-of-concept study evaluated receptor-targeted sequential dosing using phages Dobby, targeting lipopolysaccharide, and MPK7, targeting type IV pili, against P. aeruginosa PAO1.
    METHODS: Time-kill assays were conducted at various multiplicities of infection (MOI: 0.01, 1, and 100) to compare simultaneous and sequential dosing regimens. Resistance profiling was performed to assess the fitness costs of resulting isolates, while atomic force microscopy infrared spectroscopy (AFM-IR) was utilized to identify chemical signatures and underlying resistance mechanisms in phage-resistant mutants.
    RESULTS: Sequential treatment, particularly initiating therapy with the LPS-specific phage Dobby followed by MPK7, was more effective than simultaneous dosing, achieving bacterial reductions exceeding 3-log10 within 48 h. Notably, low MOI (0.01) sequential treatments maintained sustained population suppression, whereas high MOI (100) treatments triggered rapid bacterial rebound. Resistance profiling confirmed that Dobby-resistant isolates exhibited lower fitness costs, rendering them more susceptible to subsequent MPK7 treatment. AFM-IR revealed unique chemical alterations in resistant mutants, specifically linked to LPS truncation and TFP dysfunction.
    CONCLUSIONS: In the Dobby-MPK7-PAO1 model, receptor-specific sequential dosing produced more sustained bacterial suppression than simultaneous treatment. This proof-of-concept supports further evaluation of temporal phage dosing across diverse P. aeruginosa strains and phage combinations.
    Keywords:   pseudomonas aeruginosa ; AFM-IR spectroscopy; antimicrobial resistance; bacteriophage therapy; drug delivery; phage cocktail; sequential phage treatment; type IV pili (TFP)
    DOI:  https://doi.org/10.1007/s11095-026-04207-z
  33. Diagnostics (Basel). 2026 Nov 06. pii: 3677. [Epub ahead of print]16(21):
      Legionella pneumophila is a major cause of severe community-acquired pneumonia and one of the most lethal respiratory pathogens. Nevertheless, it remains substantially underdiagnosed because conventional diagnostic assays are slow, insensitive, or limited to specific serogroups. In this narrative review, we integrate fragmented literature regarding Legionella pneumonia, covering its intracellular pathogenesis, clinical spectrum and patient management. Evidence was identified through a structured search of PubMed/MEDLINE and Europe PMC (23 September 2026) and prioritized by design, with primary clinical and mechanistic studies and systematic reviews taking precedence over narrative summaries and with society guidelines used to anchor management recommendations. We argue that this field is undergoing a diagnostic paradigm shift fueled by culture-independent molecular assays. We first review the Dot/Icm type IV secretion system and intracellular lifecycle that allow Legionella to replicate within macrophages while evading host innate immunity. We then summarize the full clinical spectrum, ranging from self-limited Pontiac fever to fatal Legionnaires' disease complicated by acute respiratory distress syndrome, as well as epidemiological characteristics including waterborne transmission and outbreak risks. The core of this review examines how metagenomic next-generation sequencing, targeted NGS, plasma microbial cell-free DNA and syndromic multiplex PCR are reshaping diagnostic workflows, and compares the strengths and limitations of these novel tools with urinary antigen testing and bacterial culture. Pooled estimates place the sensitivity of urinary antigen testing at 0.79 overall and 0.86 for serogroup 1, and that of respiratory PCR at 97.4%, with specificities of 1.00 and 0.99, respectively. We further evaluate contemporary therapeutic evidence, including fluoroquinolone versus macrolide monotherapy, combination regimens, and adjunctive corticosteroid therapy. Throughout this review, we highlight that Legionella is a pathogen whose clinical presentation, diagnostic yield and prognosis are highly dependent on host immune status, exposure setting and appropriate diagnostic stewardship. We conclude by identifying critical knowledge gaps and outlining a framework for diagnosis-driven precision antimicrobial management of this underrecognized pathogen. That framework is an evidence-informed synthesis rather than a validated pathway: no prospective study has yet shown that it improves patient outcomes, and its cost-effectiveness has not been measured.
    Keywords:  Legionella pneumophila; Legionnaires’ disease; diagnostic stewardship; intracellular pathogenesis; metagenomic next-generation sequencing; precision antimicrobial management; urinary antigen
    DOI:  https://doi.org/10.3390/diagnostics16213677
  34. Genome Med. 2026 Aug 13. pii: 175. [Epub ahead of print]18(1):
       BACKGROUND: Patients with advanced chronic liver disease (ACLD) and underlying cirrhosis frequently require repeated courses of antimicrobial therapy, with both the frequency and spectrum of antimicrobial exposure increasing alongside disease progression. In this population, impaired immune function and increased intestinal barrier dysfunction contribute to a heightened susceptibility of multidrug-resistant bacterial infections.
    METHODS: To comprehensively characterise the gastrointestinal microbiome and antimicrobial resistance gene (ARG) landscape across the clinical spectrum of ACLD, and to identify microbial and resistome signatures associated with disease severity, we employed long-read metagenomic sequencing (Oxford Nanopore Technologies) to profile the gastrointestinal microbiome and resistome in patients with acute-on-chronic liver failure (ACLF), decompensated cirrhosis (DC), and stable cirrhosis (SC), compared to healthy controls (HC).
    RESULTS: ACLF patients showed marked enrichment of Enterococcus faecium, with six of 28 samples showing >95% relative abundance, highlighting its potential as a bacterial biomarker of advanced cirrhosis. We reconstructed 28 high-quality metagenome-assembled genomes (MAGs) of E. faecium from cirrhosis patients, 17 from ACLF cases. E. faecium dominance was associated with substantially reduced microbial diversity and a marked depletion of key commensal taxa, including Blautia, Akkermansia, Faecalibacterium, and Bifidobacterium. Consistent with these compositional shifts, resistome analysis revealed significant enrichment of clinically relevant antimicrobial resistance genes (ARGs) in DC and ACLF, including determinants conferring resistance to aminoglycosides, beta-lactams, and glycopeptides, consistent with prior antimicrobial exposure.
    CONCLUSION: Long-read metagenomics enables high-resolution characterisation of microbial and resistome dynamics across ACLD severities. By capturing taxonomic shifts, functional potential, and ARG enrichment, this approach provides valuable insights into microbiome trajectories linked with disease severity, informing mechanistic research and potential clinical interventions.
    Keywords:   Enterococcus faecium ; Acute-on-chronic liver failure (ACLF); Advanced chronic liver disease (ACLD); Antimicrobial resistance (AMR); Cirrhosis; Gut microbiome; Long-read metagenomics; Metagenome-assembled genomes (MAGs); Oxford Nanopore Technologies; Resistome
    DOI:  https://doi.org/10.1186/s13073-026-01724-9
  35. Front Cell Infect Microbiol. 2026 ;16 1912867
      Implant-associated orthopedic infections remain difficult to eradicate because biofilm persistence is coupled to progressive changes in bone and local immunity. This narrative review presents the Bone-biofilm Interface (BBI) as an integrative framework linking microbial biofilms, implant properties, bone cells, immune cells, and the mineralized matrix. Its contribution is primarily organizational: it consolidates evidence on intracellular bacterial reservoirs, inflammatory osteolysis, immune dysfunction, and biofilm adaptation within a single spatial and functional unit. The framework also advances testable, but not yet clinically established, hypotheses concerning ion-mediated matrix remodeling, the dual role of osteoclasts as resorptive cells and potential bacterial reservoirs, and niche-dependent transitions between dormancy and resuscitation. We further consider how polymicrobial communities, temporal evolution, and implant material properties may modify these interactions. The available evidence is weighted according to source, with human observations distinguished from animal and in vitro studies. Established clinical management, including surgical source control and guideline-based antimicrobial therapy, remains central; proposed approaches involving microenvironment modulation, metabolic interference, immune reprogramming, anti-resorptive agents, and responsive biomaterials should be viewed as investigational adjuncts. By clarifying evidence boundaries and translational readiness, the BBI framework provides a structured research agenda for testing how disruption of host-microbe crosstalk might complement current treatment of chronic implant-associated infection.
    Keywords:  Staphylococcus aureus; biofilm; bone microenvironment; host-pathogen interaction; immune evasion; orthopedic implant infection; osteolysis; persister cells
    DOI:  https://doi.org/10.3389/fcimb.2026.1912867
  36. Int J Mol Sci. 2026 Oct 24. pii: 9510. [Epub ahead of print]27(21):
      Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disorder in which epithelial injury, immune activation, and stromal remodelling are organised into local tissue niches. Bulk and single-cell RNA sequencing have defined important cell states, but dissociation removes the anatomical relationships needed to determine where those states coexist. Spatial transcriptomics (ST) addresses this gap by mapping RNA, and in some platforms, protein, onto intact sinonasal tissue. This review provides an evidence-graded synthesis organised around a single translational chain: spatial niche to molecular signature to plausible biological mechanism to CRS phenotype/endotype to clinical implication to therapeutic relevance to validation status. Direct CRS ST evidence is separated from single-cell RNA sequencing support, computational prediction, protein or in situ evidence, experimental perturbation, clinical validation, and extrapolation from other inflammatory diseases. Current CRS studies support spatial compartmentalisation of eosinophil-rich epithelial lesions, ALOX15-positive macrophage programmes, GZMK-positive CD8 T-cell-fibroblast neighbourhoods, and treatment-associated epithelial and stromal changes. However, most ligand-receptor calls remain predictive, and spatial association alone does not establish functional causality. ST is therefore best viewed as a discovery and mechanistic-prioritisation technology whose clinical promises-biomarker selection, biologic matching, and response monitoring-require independent cohorts, locked assays, patient-level reproducibility, and prospective outcome studies. We compare study designs and platforms, examine statistical issues including spatial autocorrelation and pseudoreplication, and propose a cautious translational framework in which orthogonal and clinical validation convert spatial observations into actionable evidence.
    Keywords:  chronic rhinosinusitis; chronic rhinosinusitis with nasal polyps; evidence grading; immune niche; precision medicine; single-cell RNA sequencing; spatial transcriptomics; tissue remodelling
    DOI:  https://doi.org/10.3390/ijms27219510
  37. Periodontol 2000. 2026 Nov 09.
       BACKGROUND: The primary objective of periodontology is to prevent and treat gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. The connection between periodontitis and serious systemic diseases underscores the need to extend periodontal healthcare to individuals across all income levels. A public health initiative needs to employ anti-infective treatment that effectively targets key periodontal pathogens, delivers long-term benefits, and is safe and affordable.
    MATERIALS AND METHODS: Research papers by experienced researchers in clinical periodontics show shortcomings with traditional (mechanical) treatment of moderate-to-severe periodontitis (stage 3/4), most likely because of an inability to eradicate periodontal pathogens residing within inflamed gingiva and deep furcation sites. This article proposes augmenting current treatment of severe periodontitis with systemic and local chemotherapeutics against major periodontal pathogens, including active herpesviruses, various anaerobic bacteria, and dental biofilm microorganisms. The therapeutic effectiveness of the individual parts of the suggested therapy is well recognized.
    RESULTS: The recommended treatment protocol includes (i) valacyclovir for periodontal herpesviruses on treatment days 1-4, (ii) a pause in pharmacotherapy on days 5-6 to prevent adverse drug interactions, (iii) antibacterial antibiotics like ciprofloxacin-metronidazole on days 7-11, and (iv) biofilm antiseptics such as sodium hypochlorite for ultrasonic scaling and patient self-care. The professional anti-infective therapy may be completed during two office visits on treatment days 1 and 7. Published studies show promising therapeutic outcomes.
    CONCLUSIONS: The suggested anti-infective treatment is readily integrated into clinical practice and can be performed as a standalone or an adjunct to traditional periodontal treatment. The treatment is effective, highly safe, and affordable. Dental hygienists can perform a major part of the periodontal therapy.
    CLINICAL RELEVANCE: This article highlights a decade-long paradigm shift in periodontology, moving from almost purely physical cleaning to an integrated approach of traditional periodontal methods and targeted pharmaceutical therapies. The hypothetical anti-infective chemotherapy presented here is low-cost and effective against periodontal pathogens involved in severe periodontitis, peri-implantitis, and probably also periodontal-related systemic diseases. Research is encouraged on the potential of this and future anti-infective treatments to arrest severe periodontitis and reduce the incidence and severity of systemic diseases related to periodontal disease.
    Keywords:  anti‐infective therapy; focal infection; herpesviruses; periodontitis; periodontopathic bacteria
    DOI:  https://doi.org/10.1111/prd.70099
  38. Front Bioinform. 2026 ;6 1908527
      Salmonella remains one of the leading foodborne pathogens associated with poultry, posing significant challenges to animal health, food safety, and public health worldwide. Conventional control strategies have largely focused on pathogen elimination through antimicrobials, biosecurity, and vaccination; however, increasing evidence suggests that Salmonella persistence is strongly influenced by interactions within complex microbial ecosystems. This review synthesizes current knowledge on how microbial communication networks regulate the colonization, persistence, and transmission of Salmonella throughout poultry production systems. Particular emphasis is placed on quorum sensing, metabolic cross-feeding, competitive exclusion, interkingdom signaling, biofilm-associated interactions, and ecological communication occurring within the gut, litter, water systems, and other environmental reservoirs. Recent studies demonstrate that microbial community structure and function influence pathogen behavior through coordinated signaling pathways and indirect ecological interactions that collectively determine colonization resistance and ecosystem resilience. Emerging microbiome engineering approaches, including defined microbial consortia, prebiotics, probiotics, quorum-sensing inhibitors, and ecological network manipulation, offer promising alternatives to conventional pathogen-directed interventions. Integrating microbial ecology with multi-omics technologies and systems biology is expected to facilitate precision microbiome-based strategies for sustainable Salmonella control. Viewing Salmonella as a participant in interconnected microbial communication networks rather than an isolated pathogen provides a conceptual framework for developing innovative interventions that improve poultry health, enhance food safety, and support One Health objectives.
    Keywords:  Salmonella; colonization resistance; microbial communication; poultry microbiome; quorum sensing
    DOI:  https://doi.org/10.3389/fbinf.2026.1908527
  39. J Tissue Viability. 2026 Nov 03. pii: S0965-206X(26)00098-7. [Epub ahead of print]36(1): 101080
       BACKGROUND: Diabetic foot ulcer (DFU) severity, a determinant of amputation and death, may be associated with the C-reactive protein-triglyceride-glucose index (CTI), an inexpensive marker integrating inflammation and insulin resistance, though this association remains unclear.
    METHODS: 1016 patients with DFU were included. DFU severity was classified as mild (Wagner grade < 3) or severe (Wagner grade ≥ 3). Multivariable logistic regression, restricted cubic spline, ROC curve, subgroup, and sensitivity analyses evaluated the association between CTI and DFU severity. Exploratory hematoxylin and eosin staining of wound-margin tissues (n = 15) assessed inflammatory cell infiltration.
    RESULTS: CTI was independently and positively associated with DFU severity. In the fully adjusted model, the odds ratio (OR) for severe DFU in the highest CTI quartile was 3.06 (95% CI: 1.87-5.08; P for trend < 0.001). Each one-unit increment in CTI increased the risk of severe DFU by 51% (OR = 1.51, 95% CI: 1.27-1.79). RCS analysis demonstrated a linear positive association between CTI and DFU severity. Adding CTI to the conventional model improved the area under the ROC curve from 0.659 to 0.686 (DeLong test P = 0.014). In the histological subset, inflammatory cell infiltration was greater in the CTI-high group and lymphocyte counts higher in severe DFU (both P < 0.05).
    CONCLUSION: CTI was independently associated with DFU severity and improved the discriminative performance of conventional models, suggesting its value as an accessible marker for assessing DFU severity.
    Keywords:  C-reactive protein; C-reactive protein-triglyceride-glucose index; Diabetic foot ulcer; Insulin resistance
    DOI:  https://doi.org/10.1016/j.jtv.2026.101080
  40. J Hosp Infect. 2026 Nov 12. pii: S0195-6701(26)00431-7. [Epub ahead of print]
      Catheter-associated urinary tract infections (CAUTIs) are major contributor to healthcare-associated morbidity and are increasingly associated with multidrug-resistant (MDR) pathogens. We performed whole-genome sequencing of paired catheter and urine-derived isolates from five CAUTI cases identified prospectively in a Portuguese hospital (February-July 2024) to characterize species diversity, resistomes, virulence, strain relatedness and genomic variation. Substantial heterogeneity was observed in bacterial species and genomic profiles. Escherichia coli predominated in catheter (57%) and urine (67%) samples, consistent with its recognized role in early colonization under the short dwell times observed (median: 5 days). Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis occurred sporadically, mainly in catheter associated samples. Four patients harboured isogenic or near-isogenic catheter-urine pairs, consistent with closely related strains across compartments, whereas ondistinct E. coli lineages (ST12 vs. ST131) were identified in one patient. AMR profiles ranged from limited repertoires to extensive MDR. High-risk E. coli ST131 isolated carried characteristic ESBL and fluoroquinolone-resistance determinants but were genomically distinct. Virulence repertoires encompassed factors associated with adhesion, biofilm formation, iron acquisition, immune evasion and epithelial injury (including colibactin in one catheter isolate), alongside biocide- and stress-response determinants. Matched catheter-urine pairs showed limited genomic divergence, with few or no detected variants and no predicted variant-associated changes in antimicrobial susceptibility. These findings illustrate that early CAUTI cases may involve MDR high-risk clones and heterogeneous catheter-urine genomic profiles. Genomic characterization may complement conventional microbiology in the investigation of CAUTI, supporting future studies of pathogen-source assessment, antimicrobial management and infection-control strategies.
    Keywords:  CAUTI; Escherichia coli ST131; Klebsiella pneumoniae; MDR; Virulome and Resistome; WGS; Within-Host Microevolution
    DOI:  https://doi.org/10.1016/j.jhin.2026.10.027
  41. Foods. 2026 Oct 25. pii: 3815. [Epub ahead of print]15(21):
      Campylobacter (C.) jejuni and C. coli are major foodborne bacterial pathogens, and multiple mechanisms, including biofilm formation, antimicrobial resistance (AMR), and genetic variability, contribute to their persistence in poultry-associated environments. However, the relationships among these traits remain poorly understood. This study investigated 120 Campylobacter isolates (78 C. jejuni and 42 C. coli) from retail raw chicken meat by integrating assessments of biofilm formation under two different atmospheric conditions, antibiotic susceptibility profiles, AMR and virulence-associated determinants, and repetitive sequence-based polymerase chain reaction (rep-PCR)-based genetic diversity. Biofilm formation was highly heterogeneous, with atmospheric composition being associated with biofilm biomass accumulation rather than the overall occurrence of biofilm-forming isolates. Although comparable proportions of biofilm formers were detected under microaerophilic (47.5%) and aerobic carbon dioxide (CO2)-enriched (45.8%) conditions, increased oxygen was associated with isolate-specific shifts toward increased biofilm biomass, with no significant overall difference. High resistance frequencies were observed for tetracycline (TE) and ciprofloxacin (CIP), with TE + CIP representing the predominant combined resistance phenotype; however, biofilm formers did not show broader AMR profiles and were less often resistant to multiple antimicrobial classes. Genotype-phenotype analyses showed strong associations between gyrA mutation and CIP resistance and between tet(O) detection and TE resistance, whereas the multidrug efflux-associated gene cmeB showed only a weak, species-dependent association with antimicrobial response complexity and not with a single resistance phenotype. Overall, biofilm formation was mainly associated with species, with a weaker association with rep-PCR cluster, and was not associated positively with AMR among this collection of poultry-associated Campylobacter isolates. These findings support assessing biofilm-forming capacity and AMR separately in these bacteria, rather than relying on one trait to infer the other. They also suggest that Campylobacter, inherently susceptible to antimicrobials, may favor biofilm formation as an alternative survival strategy.
    Keywords:  Campylobacter; antibiotic resistance; association analysis; biofilm formation; food safety; genetic diversity; rep-PCR; virulence factors
    DOI:  https://doi.org/10.3390/foods15213815
  42. Curr Res Microb Sci. 2026 Dec;11 100674
      Porphyromonas gingivalis is a keystone oral pathogen implicated in periodontitis and several other pro-inflammatory or degenerative diseases. Previous studies showed that outer membrane vesicles (OMVs) produced by this Gram-negative bacterium are loaded with virulence factors, including the P. gingivalis peptidyl-arginine deiminase (PPAD). However, our understanding of strain-specific OMV features and the impact of PPAD on OMV cargo composition was so far limited. Therefore, the present study was aimed at comparing OMV proteomes of six different P. gingivalis strains, including PPAD-proficient and -deficient variants of the type strains W83 and ATCC 33277, and two clinical isolates. Per strain, 100-203 OMV-borne proteins were identified, originating mostly from the bacterial periplasm and outer membrane. The OMV core proteome included 79 orthogroups representing 11 biological pathways. Interestingly, 23 identified OMV cargo proteins were related to the type IX secretion system (T9SS) for export of virulence factors, invariably including all four components of the so-called T9SS attachment complex. PPAD-deficiency altered the OMV protein content by ∼18% compared to OMVs from the respective PPAD-proficient strains. Lastly, the investigated OMVs invariably carried multiple proteins involved in iron and heme acquisition. Accordingly, we demonstrate for the first time that P. gingivalis OMVs are highly potent inducers of hemagglutination and to lesser extent hemolysis of human erythrocytes. In conclusion, our present proteome analyses disclose interactions of P. gingivalis OMVs with human erythrocytes related to heme and iron acquisition, and they suggest that attachment to erythrocytes could represent a plausible mechanism for OMV dissemination throughout the human body.
    Keywords:  Erythrocytes; Hemagglutination; Hemolysis; OMVs; PPAD; Porphyromonas gingivalis; Proteome; T9SS
    DOI:  https://doi.org/10.1016/j.crmicr.2026.100674
  43. New Microbes New Infect. 2026 Dec;74 101880
       Background: Combat-related injuries sustained during the ongoing conflict in Ukraine have been associated with infections caused by multidrug-resistant Gram-negative bacteria, raising concerns about treatment options and cross-border transmission to receiving healthcare systems. Pseudomonas aeruginosa is among the most clinically significant pathogens in this setting. This study aimed to define the molecular epidemiology of P. aeruginosa from combat-related wounds in Ukraine and to link genomic resistance and virulence determinants to antimicrobial susceptibility and virulence phenotypes.
    Methods: P. aeruginosa isolates from distinct wound patients (n = 13, Dec 2024-Jun 2025) underwent whole-genome sequencing, SNP-based phylogenetic analysis, and screening of acquired resistance genes and chromosomal resistance-associated mutations. Antimicrobial susceptibility testing followed EUCAST, and carbapenemase production was assessed phenotypically. Virulence profiling included exoU/exoS carriage, 3-oxo-C12-HSL and C4-HSL production, and pyocyanin and rhamnolipid production.
    Results: Ten sequence types were identified, including ST235, ST244, ST773, and ST1047, indicating high clonal diversity rather than a single outbreak lineage. All isolates were non-susceptible to ciprofloxacin, ceftazidime, piperacillin-tazobactam, and aztreonam; 5/13 were non-susceptible to ceftolozane-tazobactam and 4/13 were meropenem-resistant. Carbapenemase-positive isolates carried blaIMP-1 (3/13) or blaNDM-1 (1/13). Resistance-associated chromosomal variation affected porins, efflux regulators, and β-lactam response pathways. Virulence profiles were heterogeneous, with mutually exclusive exoU (7/13) or exoS (6/13) carriage and variable pyocyanin and rhamnolipid production.
    Conclusions: These data provide genomic and phenotypic characterisations of combat-wound P. aeruginosa from Ukraine, highlighting substantial diversity and frequent multidrug-resistant phenotypes and supporting lineage-resolved genomic surveillance in conflict-associated care pathways.
    Keywords:  Antimicrobial resistance; Carbapenemase; Combat-related wounds; Molecular epidemiology; Pseudomonas aeruginosa; Whole-genome sequencing
    DOI:  https://doi.org/10.1016/j.nmni.2026.101880
  44. Front Immunol. 2026 ;17 2023428
      
    Keywords:  antimicrobial resistance; biofilms; enteric disease; gut microbiota; host–microbiome interactions; immune regulation; intestinal barrier; probiotics
    DOI:  https://doi.org/10.3389/fimmu.2026.2023428
  45. Can J Neurol Sci. 2026 Nov 13. 1-8
      Emerging evidence increasingly implicates chronic periodontal disease as a contributor to age-related cognitive decline and dementia, including Alzheimer's disease (AD). Periodontitis is defined by persistent oral microbial dysbiosis, ulcerated gingival epithelium, repeated bacteremia and sustained systemic inflammatory signaling - factors that plausibly influence neuroimmune pathways and cerebrovascular integrity. This review synthesizes findings from epidemiological studies, systematic reviews, mechanistic analyses and experimental models to examine the biological links between oral inflammation and neurodegeneration. Collectively, the literature suggests a stepwise oral-brain axis: first gingival inflammation promotes local and systemic pro-inflammatory cytokine release, second repeated bacteremia allows oral pathogens and microbial byproducts to enter circulation, third these signals and agents access and compromise the blood-brain barrier, then fourth microglia in the brain become primed and hyper-reactive and at last enhanced neuroinflammation accelerates amyloid-β and tau pathology. Although causal inference remains limited by the predominance of observational data, emerging intervention studies and mechanistic evidence suggest that periodontal health is a potentially modifiable factor in dementia prevention strategies.
    Keywords:  Alzheimer’s disease; cognitive impairment; dementia; neuroinflammation; periodontitis
    DOI:  https://doi.org/10.1017/cjn.2026.10704
  46. Sci Rev. 2026 ;1(1): 29
      Although antimicrobial resistance (AMR) is traditionally viewed as a consequence of antibiotic selection, growing evidence indicates that bacterial immune systems regulate which mobile genetic elements (MGEs) successfully enter, establish, and persist within bacterial populations. Here, we argue that bacterial immunity helps determine access to the mobile resistome and, consequently, shapes the evolutionary opportunities upon which antibiotic selection acts. This review synthesizes current evidence on the interplay between bacterial immunity, counter-defense mechanisms, and MGE-MGE conflict, highlighting how these interactions collectively influence the entry, survival, expression, persistence, and transmission of foreign DNA. We further discuss recent discoveries revealing a far greater diversity of bacterial defence and MGE counter-defence strategies than previously recognized, including conflicts extending beyond genome protection to the regulation of gene expression, and consider how this expanding molecular repertoire influences MGE accessibility and the mobile genetic variation available for AMR evolution. By integrating concepts that are typically discussed separately, we propose that immunity, counter-defense, and MGE competition collectively regulate access to the vast and largely uncatalogued mobile gene pool from which resistance determinants are acquired. Viewed through this framework, AMR emerges not only from antibiotic selection, but also from the evolutionary processes that determine which genetic variants become available for selection, providing a broader perspective on resistance emergence and the uneven distribution of high-risk resistant lineages.
    Keywords:  Antimicrobial resistance; Bacterial immunity; Defense islands; Horizontal gene transfer; Mobile genetic elements
    DOI:  https://doi.org/10.1038/s44573-026-00027-9
  47. Front Med (Lausanne). 2026 ;13 1995724
       Background: ESKAPE pathogens are the leading cause of hospital-acquired infections (HAIs) in intensive care units (ICUs) and are increasingly associated with multidrug resistance, posing a major challenge to patient management worldwide. This study evaluated seven-year changes in the epidemiology of ESKAPE pathogens and their antimicrobial resistance in ICUs of a tertiary hospital.
    Methods: This retrospective observational surveillance study analysed microbiological isolates obtained from patients with hospital-acquired infections treated in the multidisciplinary ICU in 2017 and in the subsequently formed surgical and non-surgical ICUs in 2024 at least 48 h after admission to the ICU. The distribution of ESKAPE pathogens and antimicrobial susceptibility patterns were compared between study periods and ICU settings using χ 2 or Fisher's exact test, with statistical significance set at p < 0.05.
    Results: A total of 1,113 microbiological isolates were analysed. ESKAPE pathogens accounted for more than 70% of microbiologically confirmed hospital-acquired infections in all investigated ICUs. Although their overall proportion remained stable over the seven-year period, the distribution of individual pathogens changed substantially. Acinetobacter baumannii remained the predominant pathogen in the multidisciplinary and non-surgical ICUs, whereas Klebsiella pneumoniae became the leading isolate in the surgical ICU. Antimicrobial resistance increased significantly, particularly among A. baumannii and K. pneumoniae. In 2024, carbapenem resistance in K. pneumoniae approached 75%, while A. baumannii exhibited resistance exceeding 75% to most routinely tested antimicrobial agents, leaving very limited therapeutic options.
    Conclusions: Although the overall prevalence of ESKAPE pathogens remained relatively unchanged, significant shifts occurred in the distribution of individual pathogens together with a substantial increase in antimicrobial resistance over the seven-year period. Continuous local microbiological surveillance is essential for optimizing empirical antimicrobial therapy, supporting antimicrobial stewardship programs and strengthening infection prevention strategies in intensive care units.
    Keywords:  ESKAPE pathogen; antibiotic resistance; epidemiology; hospital-acquired infections; intensive care unit
    DOI:  https://doi.org/10.3389/fmed.2026.1995724
  48. BMC Microbiol. 2026 Oct 12. pii: 990. [Epub ahead of print]26(1):
       OBJECTIVE: To characterize the population structure, antimicrobial resistance landscape, and virulence potential of Elizabethkingia meningoseptica based on publicly available genomes and a clinical isolate E0725.
    METHODS: We analyzed 96 public genomes together with E0725 for core-genome single-nucleotide polymorphisms (SNPs), average nucleotide identity (ANI), antimicrobial resistance genes, and virulence genes. E0725 was further evaluated by antimicrobial susceptibility testing, biofilm formation, Galleria mellonella infection, serum resistance, bile salt tolerance, and oxidative-stress assays.
    RESULTS: The 97 strains belonged to multiple genetic lineages with weak geographic clustering and few near-clonal clusters. BlaB-, GOB-, CME-, and RASA-like β-lactamases and conserved core virulence genes were widely present, whereas variation mainly involved accessory resistance genes and cell-surface structure genes. E0725 was multidrug-resistant and showed strong biofilm formation, serum resistance, bile salt tolerance, and lethality in G. mellonella, but was sensitive to hydrogen peroxide.
    CONCLUSION: E. meningoseptica is genetically diverse, with a conserved intrinsic resistance backbone and variable accessory genomic features. The clinical isolate E0725 exhibited strain-specific phenotypic traits associated with biofilm formation, serum tolerance, and host-associated adaptation. Accurate identification, isolate-specific susceptibility testing, genomic surveillance, and management of hospital water systems should be prioritized for infection control.
    CLINICAL TRIAL NUMBER: Not applicable.
    Keywords:   Elizabethkingia meningoseptica ; Antimicrobial resistance; Core-genome SNPs; Genomic epidemiology; Pathogenic phenotypes; Virulence
    DOI:  https://doi.org/10.1186/s12866-026-05766-2
  49. Curr Microbiol. 2026 Nov 07. pii: 626. [Epub ahead of print]83(12):
      Antimicrobial resistance (AMR) is an emerging global health threat responsible for antibiotics being ineffective, leading to persistent infections, increased mortality, and healthcare costs. ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens have a higher priority worldwide for the development of therapeutic approaches other than traditional antibiotics. Quorum sensing (QS) links population-dependent gene expression with a mechanistic understanding of bacterial communication, virulence regulation, and biofilm-associated persistence. Major QS systems across ESKAPE pathogens are Agr and accessory gene regulator networks in Gram-positive bacteria; LuxS/AI-2 signaling; the LuxI/LuxR-family systems in Gram-negative bacteria; the Las, Rhl, and Pseudomonas quinolone signal (PQS) networks in P. aeruginosa; and the AbaI/AbaR system in A. baumannii. This review focuses on QS regulatory mechanisms in ESKAPE pathogens and discusses the novel approaches to target QS-associated virulence and biofilm formation. A review of the literature on QS signaling pathways, biofilm regulation, and anti-QS therapies was performed with special focus on combating strategies like plant-derived phytochemicals, synthetic QS inhibitors, enzymatic quorum quenching, probiotics, and combinations of QS-targeted agents with conventional antibiotics. QS systems are involved in virulence regulation, adhesion, biofilm maturation, and bacterial persistence. Plant-based compounds such as flavonoids, alkaloids, terpenoids, and polyphenols have been shown to have potential to interfere with QS-related processes. Synthetic inhibitors, quorum-quenching enzymes, probiotics, and antibiotic combination strategies are also promising approaches. By integrating QS regulation with virulence, biofilm biology, and antimicrobial response across ESKAPE pathogens, this review provides a comparative framework to guide future target prioritization, diagnostic development, and evaluation of adjunctive anti-virulence strategies. Mechanistic validation, standardized cross-pathogen comparisons, and long-term resistance-evolution studies are needed to establish the therapeutic readiness and clinical value of these approaches.
    DOI:  https://doi.org/10.1007/s00284-026-05213-5
  50. Cells. 2026 Nov 05. pii: 2016. [Epub ahead of print]15(21):
      Periodontal health and disease are shaped by a dynamic interaction between the subgingival microbiome and the host immune system, in which gingival macrophages contribute to tissue homeostasis, disease progression, and inflammation resolution. Here, we investigated how three periodontitis-associated bacteria, Fusobacterium nucleatum, Porphyromonas gingivalis, and Tannerella forsythia, shape the polarization of human macrophages in vitro. THP-1 monocytes were differentiated into unpolarized M0 macrophages, or polarized toward the M1 or M2 phenotype, and infected with each bacterium at different multiplicities of infection. Polarization was assessed from the surface expression of CD80 (M1) and CD209 (M2) and from pro- and anti-inflammatory cytokine production, measured by a multiplex assay. The response to P. gingivalis differed strikingly from the two other species. Porphyromonas gingivalis suppressed both M1 and M2 polarization and reduced the levels of several pro- and anti-inflammatory cytokines. In contrast, F. nucleatum and T. forsythia enhanced CD80 expression and pro-inflammatory cytokine production in M1 macrophages and modestly increased pro-inflammatory mediators in M2 macrophages. These findings point to a distinct role for P. gingivalis as a keystone pathogen that subverts the innate immune response, and for F. nucleatum and T. forsythia as periodontal pathobionts.
    Keywords:  THP-1 macrophages; innate immunity; keystone pathogen; macrophage polarization; pathobiont; periodontitis
    DOI:  https://doi.org/10.3390/cells15212016
  51. Front Cell Infect Microbiol. 2026 ;16 1951083
       Background: Clear aligners create an aligner-tooth interface that may retain saliva, microorganisms, and dietary substrates. Evidence linking interface properties, oral microecological responses, and preventive interventions remains fragmented.
    Objective: To map and synthesize evidence on clear aligner interface properties and microbial adhesion, oral microbial ecology during clear aligner wear, and strategies for biofilm control and caries-risk mitigation.
    Methods: Following Joanna Briggs Institute methodology and PRISMA-ScR guidance, PubMed, Embase, and Web of Science Core Collection were searched from inception to August 31, 2026, without language restrictions. Backward and forward citation searching supplemented database searches. Original clinical, in vitro, and ex vivo studies involving active clear aligner treatment, associated materials or interfaces, or clear-aligner-specific interventions were eligible when they reported microbial, biofilm, microbiome, metabolomic, caries-related, or mineral outcomes. Two reviewers independently screened records; two authors charted and verified data. Findings were synthesized descriptively within three evidence domains.
    Results: Of 988 records, 132 reports were included. Because reports could contribute to more than one domain, 62 informed interface properties and microbial adhesion, 47 oral microbial ecology during wear, and 76 biofilm control and caries-risk mitigation. No single polymer, manufacturing method, or surface parameter consistently predicted microbial adhesion or biofilm formation. Outcomes reflected interactions among material characteristics, local topography, salivary conditioning, aging and exposure, microbial species, and experimental models. Clinical microbial responses were compartment- and time-dependent. Salivary and tooth-associated communities often remained relatively stable at the community level, whereas the inner aligner surface sometimes exhibited localized taxonomic, functional, metabolic, and pH-related changes. Investigated interventions included cleaning, antimicrobial and antifouling interface modifications, anticaries and remineralizing approaches, probiotics, and environment-responsive systems. Although many strategies reduced microbial burden, biofilm-related outcomes, acidogenicity, or mineral loss under tested conditions, evidence was predominantly short-term and preclinical. Assessments of durability, material performance, and safety were heterogeneous.
    Conclusions: Clear aligner-microbiota interactions appear context-dependent rather than uniformly favorable or unfavorable. Evidence neither establishes causal relationships between interface or microecological changes and clinical disease nor identifies a universally superior intervention. More standardized, clinically representative evidence may clarify their clinical relevance and inform preventive management during clear aligner treatment.
    Keywords:  antibiofilm strategies; caries prevention; clear aligners; interface properties; oral microbial ecology
    DOI:  https://doi.org/10.3389/fcimb.2026.1951083
  52. Nutr Metab Cardiovasc Dis. 2026 Oct 15. pii: S0939-4753(26)00498-9. [Epub ahead of print] 105036
       BACKGROUND AND AIM: To evaluate the association between an intensive prevention protocol and diabetic foot ulcer (DFU) recurrence.
    METHODS AND RESULTS: Monocentric retrospective study of patients with healed DFUs managed in a multidisciplinary diabetic foot service (2015-2024). Patients received either a standard protocol (SP; podiatric care, therapeutic footwear, patient education) or an intensive protocol (IP) delivered in a dedicated prevention service with reinforced education and close monitoring of therapeutic footwear use. One-year recurrence-free survival and recurrence-related amputation rates were compared. Overall, 331 patients were included (SP,n = 127; IP,n = 204); mean age was 72 ± 8.4 years, 66.8% were male, and 93.3% had type 2 diabetes. Baseline characteristics were similar, although the IP group had higher rates of minor amputation (40.2% vs. 23.6%, p = 0.02) and smoking (17.6% vs. 3.9%, p = 0.001). The IP group showed greater adherence to therapeutic footwear (95.6% vs. 84.2%, p = 0.001), moisturizing cream use (93.1% vs. 71.0%, p = 0.0002), and podiatric care (95.6% vs. 74.0%, p = 0.0002). At 1 year, IP showed higher recurrence-free survival (86.2% vs. 60.6%, p < 0.0001) and lower minor amputation (0.9% vs. 5.5%, p = 0.02); major amputation did not differ. Adherence to therapeutic footwear and podiatric care were independently associated with recurrence-free survival.
    CONCLUSION: An intensive integrated prevention protocol appears to be associated with a lower DFU recurrence rate.
    Keywords:  Diabetic foot ulcer; Multidisciplinary care; Recurrence; Remission; Secondary prevention
    DOI:  https://doi.org/10.1016/j.numecd.2026.105036
  53. Environ Sci Technol. 2026 Nov 10. 60(44): 31195-31210
      Biofilms represent a predominant bacterial lifestyle and contribute to the ecological stability and biochemical functioning in water systems. Paradoxically, excessive biofilm formation threatens water security and public health by causing biofouling, harboring pathogens, and facilitating the transmission of antimicrobial resistance. Phage treatment offers a promising strategy for the targeted regulation of biofilm microecology without generating harmful disinfection byproducts. However, its performance in environmental settings can be constrained by spatiotemporal heterogeneity, suboptimal phage exposure, and the evolution of phage resistance in bacteria, creating additional challenges for engineering applications. Here, we synthesize phage-based biofilm control as a multilevel intervention paradigm organized by biological bottlenecks. We examine strategies that improve transport and host access, enhance targeting and productive lysis, induce biofilm disruption through prophage activation, and perturb biofilm communities through keystone-centered interactions. We then align these intervention principles with distinct biofilm scenarios and operational constraints in engineered water environments. Emerging technologies are evaluated according to their roles in target identification, validation under application-relevant conditions, and treatment monitoring. Finally, we propose a closed-loop framework encompassing system diagnosis, intervention design and validation, monitored deployment, and adaptive management. Overall, this Review provides an integrated roadmap for advancing scalable and sustainable phage-based biofilm control in engineered water environments.
    Keywords:  bacteriophages; biofilm engineering; biofilm intervention; engineered water systems; implementation strategy
    DOI:  https://doi.org/10.1021/acs.est.6c07569
  54. Int J Mol Sci. 2026 Oct 23. pii: 9439. [Epub ahead of print]27(21):
      Quorum sensing (QS) coordinates virulence expression, biofilm-associated behavior, and persistence in Pseudomonas aeruginosa, making its signaling network a potential target for adjunctive anti-virulence therapy. Quorum quenching (QQ) directly degrades, modifies, or sequesters signaling molecules, whereas broader QS interference encompasses inhibition of signal synthesis, receptor antagonism, and disruption of downstream regulatory interactions. Experimental studies of N-acyl-homoserine lactone (AHL)-degrading enzymes and PqsR antagonists have demonstrated suppression of selected virulence-associated phenotypes, with several infection models showing reductions in host injury or persistence-associated outcomes. The PqsE-RhlR regulatory interface has gained substantial molecular and genetic support as a distinct intervention target, but its pharmacological development remains limited. Responses to QS interference vary with bacterial strain, regulatory network adaptation, environmental conditions, and infection stage. Reductions in virulence-factor production or biofilm biomass do not consistently correspond to bacterial clearance or host protection. Available human studies involving agents with proposed QS-modulatory activity have not established clinical benefits specifically attributable to QS inhibition. Clinical translation requires validated target engagement, efficacy assessment in established and polymicrobial infections, and characterization of delivery, pharmacological exposure, safety, and resistance evolution.
    Keywords:  Pseudomonas aeruginosa; anti-virulence therapy; antibiotic tolerance; biofilm; drug delivery; host protection; quorum quenching; quorum sensing
    DOI:  https://doi.org/10.3390/ijms27219439
  55. World J Surg. 2026 Nov 13.
       BACKGROUND: Diabetic foot disease is a major cause of lower limb amputation (LLA) in low- and middle-income countries (LMICs), where evidence on adjusted risk factors remains limited. This systematic review evaluates the risk factors for LLA and amputation-related mortality in diabetic foot disease across LMICs.
    METHODS: Embase, MEDLINE, the Cochrane Central Register of Controlled Trials (via Ovid), PubMed, and Scopus were searched from inception to March 2026. Studies of adults with diabetes in LMICs reporting LLA with adjusted effect estimates were included. Pooling of effect estimates was prespecified to require at least three comparable studies per domain. Risk of bias was assessed using the Newcastle-Ottawa Scale or AXIS.
    RESULTS: Sixteen studies (19,529 participants; 1604 amputation events) provided usable effect estimates; 12 reported adjusted estimates from multivariable models. No domain contained three or more comparable estimates, so quantitative synthesis was not undertaken. Osteomyelitis was independently associated with amputation in both studies assessing it (aOR 5.60, 95% CI 2.93-10.78; aOR 11.8, 95% CI 5.1-27.5). Peripheral arterial disease was associated with LLA in two of three studies using objective vascular assessment (aOR 2.80, 95% CI 1.52-5.11; aOR 3.23 per grade, 95% CI 2.68-3.89). Prior amputation was associated with LLA in two DFU cohorts reporting concordant estimates (aOR 2.86 and 3.08). Ulcer severity was associated with amputation in every study assessing it, using five different classification systems. Prolonged ulcer duration carried an adjusted odds ratio of 10.3 (95% CI 4.06-26.13), and each additional preoperative day was associated with a 9.3% increase in the odds of major amputation. Neuropathy showed no independent association of meaningful size in any adjusted analysis, and HbA1c was not associated in the largest adjusted DFU cohort analysis, although a smaller study with 10 outcome events reported a positive association.
    CONCLUSION: Peripheral arterial disease, ulcer severity, osteomyelitis, prior amputation, and delayed access to care were associated with LLA in LMIC settings. Neither neuropathy nor HbA1c showed an independent association of meaningful size in adjusted analyses of established DFU cohorts. Prospective LMIC cohorts using standardized definitions are needed.
    Keywords:  amputation; diabetic foot; low‐ and middle‐income countries; risk factors and adjusted‐risk estimates; systematic review
    DOI:  https://doi.org/10.1002/wjs.70679
  56. Int J Mol Sci. 2026 Oct 23. pii: 9479. [Epub ahead of print]27(21):
      Network pharmacology examines drug action across interacting targets, pathways, and disease modules. Increasingly, however, the graph neural networks and knowledge-graph models used for this purpose are difficult to inspect. This critical narrative review considers feature attribution, attention, counterfactual and rule-based explanation, explainable graph neural networks, Bayesian and causal methods, and path-based knowledge-graph reasoning. We assess these approaches against three demands imposed by biological graphs: preservation of heterogeneous node and relation semantics, support for multi-hop reasoning, and concordance with evidence excluded from model training. Among the methods reviewed, none has yet been shown to satisfy all three demands consistently. A model-faithful explanation may still emphasize node degree, network hubs, or heavily studied entities instead of a disease-specific mechanism. To address this problem, we propose five evaluation domains: faithfulness, stability, external biological concordance, bias sensitivity, and translational utility, together with a six-item reporting standard. Both are conceptual proposals; they remain unweighted, uncalibrated, and unevaluated empirically. An exploratory, literature-based application to TxGNN, DDI-GCN, and MINERVA shows that transparency-related reporting is useful but incomplete. This exercise demonstrates how the criteria might be used; it is not an empirical evaluation or calibration of the framework. We did not retrain or rerun any model or conduct new quantitative benchmarking. The field still lacks a unified biomedical benchmark that evaluates prediction and explanation together under heterogeneous, cold-start, and provenance-aware graph settings. Progress will depend on task-matched evaluation, explicit treatment of uncertainty, and experiments designed to distinguish what a model uses from what biology actually does.
    Keywords:  GNNExplainer; SHAP; causal explainability; explainable AI; graph neural networks; interpretability; knowledge graphs; multi-target drug discovery; network pharmacology; polypharmacology
    DOI:  https://doi.org/10.3390/ijms27219479